The Life-Extension Episode With Dr. Matt Kaeberlein | The Tim Ferriss Show | Transcription
Transcription for the video titled "The Life-Extension Episode With Dr. Matt Kaeberlein | The Tim Ferriss Show".
Note: This transcription is split and grouped by topics and subtopics. You can navigate through the Table of Contents on the left. It's interactive. All paragraphs are timed to the original video. Click on the time (e.g., 01:53) to jump to the specific portion of the video.
This episode is brought to you by levels very excited about this one I wrote about the health benefits of using continuous glucose monitors CGMs more than 10 years ago in the four-hour body and at that time CGMs were horribly primitive and hard to use super painful Levels has now made this technology and the insights that come from it easy and available to everyone Putting in the sensors everything about it is smooth easy I found it completely painless and I started tracking my glucose way back in the day to learn more about what I should and shouldn't Be eating keeping my blood sugar stable is critical to my daily and long-term health and performance goals with levels You can see how different foods affect your health with real-time feedback poor glucose control Which you don't want is associated with a number of chronic conditions not just diabetes But also Alzheimer's and heart disease it can impact your mood certainly affects my mood energy levels, right? That work in the afternoon that dip that you feel for instance That's just one example and weight management and we all respond differently sometimes a little bit sometimes Vastly differently even to the same foods. So one type of carbohydrate that my body might process Well, let's say that's fruit or rice or sweet potato Your body might not the levels app interprets your glucose data and provides a simple score after you eat a meal So you can see how different foods affect you and then develop a personalized diet. That's right for you and your goals Seeing this data in real time at least for me and for so many others who use levels is a really powerful behavioral change mechanism and Many of the guests on the podcast have talked about this Marco Canora famous chef used levels to determine that say walking For him just a few hundred steps after a meal significantly affected his glucose levels Levels is backed by a world-class team and group of advisors including names. You've likely heard before including repeat podcast guest Dr. Dom D'Agostino and many others if you're interested in learning more about levels and trying a CGM yourself Learn all about it. Go to levels dot link slash Tim. That's levels dot link slash Tim I'll spell it out Leve LS dot Li n K slash Tim check them out today I highly encourage you to consider getting this data on your own Personal responses to the food that you eat the food that maybe you shouldn't eat the food that you might want to eat more of all of these things you can learn and That is at levels dot link slash Tim. You can also find the link in this episode's description This episode is brought to you by element spelled Lmnt what on earth is element? It is a delicious sugar-free electrolyte drink mix I've stocked up on boxes and boxes of this was one of the first things that I bought When I saw kovat coming down the pike and I usually use one to two per day element is formulated to help anyone with their electrolyte needs and perfectly suited to folks following a keto low-carb or paleo diet or if you Drink a ton of water and you might not have the right balance That's often when I drink it or if you're doing any type of endurance exercise mountain biking, etc Another application if you've ever struggled to feel good on keto low-carb or paleo it's most likely because even if you're consciously consuming electrolytes, you're just not getting enough and It relates to a bunch of stuff like a hormone called aldosterone blah blah blah when insulin is low But suffice to say this is where element again spelled Lmnt can help my favorite flavor by far is citrus salt Which is a side note you can also use to make a kick-ass no sugar margarita, but for special occasions, obviously You're probably already familiar with one of the names behind it Rob wolf ro BB Rob wolf Who is a former research biochemist and two-time New York Times best-selling author of the paleo solution and wired to eat Rob created element by scratching his own itch That's how it got started his Brazilian jujitsu coaches turned him on to electrolytes as a performance enhancer things clicked and BAM Company was born So if you're on a low-carb diet or fasting electrolytes play a key role in relieving hunger cramps headaches tiredness and dizziness Sugar artificial ingredients coloring all that's garbage unneeded There's none of that in element and a lot of names you might recognize are already using element It was recommend to be by one of my favorite Athlete friends three Navy SEAL teams as prescribed by their Master Chief marine units FBI sniper teams at least five NFL teams who have subscriptions They are the exclusive hydration partner to Team USA weightlifting and on and on you can try it risk-free If you don't like it element will give you your money back. No questions asked They have extremely low return rates for a limited time. You can get a free element sample pack with any purchase It's the perfect way to try all of their flavors or if you're feeling generous sharing with a friend who might enjoy This special offer is available here at this link drink Lmnt.com slash Tim that's drink element again drink lmnt.com slash Tim At this altitude I can run flat-out for a half mile before my hands start shaking I'm a cybernetic organism living tissue over metal entoskeleton The Tim Ferriss Show Hello boys and girls ladies and germs, this is Tim Ferriss and welcome to another episode of the Tim Ferriss show my guest today is Dr. Matt Kaberlein You can find him on Twitter m kaberlein. Let me spell that for you. K a e b e r l e i n and Matt is a professor of laboratory medicine and pathology at the University of Washington School of Medicine with adjunct appointments in genome sciences and oral health Sciences, dr. Kaberlein's research interests are focused on understanding biological mechanisms of aging in order to facilitate Translational interventions that promote healthspan and improve quality of life for people and companion animals. Dr Kaberlein is the founding director of the University of Washington healthy aging and longevity research Institute the director of the NIH Nathan shock Center of Excellence in the basic biology of aging at University of Washington director of the biological mechanisms of healthy aging training program and founder and co-director of the dog aging project you can find him online at Kaberlein lab org again on Twitter at m Kaberlein and we will link to all the other social LinkedIn etc in the show notes at Tim dopp log slash Podcast Matt welcome to the show. Thanks Tim. It's a thrill to be here. I am Very excited to dive in we will run out of time probably before we run out of topics but let's just start at the basic of basics and Get a definition of aging biology first of all, I think that's actually Perhaps the hardest question you're gonna ask me today because there is really a lack of consensus I would say is first of all, what do we mean when we talk about aging and then in particular aging biology? but I'll take the simple part of that I hope and so what I think of when I think of aging biology is the biological physiological changes that occur as animals organisms age and I think the important point to appreciate I think everybody recognizes that Biologically, we are different when we are old compared to when we are young Nobody would argue with that.
Discussion On Aging Biology And Related Studies
A definition of aging biology (06:54)
I think what's important to appreciate is that there are Characteristic changes that happen in all people as we age and some of those changes happen in other animals even into very simple single-celled organisms And so when I think about the biology of aging, I think about it at different levels You can think about the molecular changes that go along with aging You can think about the functional changes that go along with aging You can think about the behavioral changes that go along with aging but those are all driven by the biology of aging and of course the last point I'll make is that Most of the major causes of death and disability and functional decline that we experience Are due to the biology of aging So if you look at all of the major killers, well almost all of the major killers in developed countries They all share a single greatest risk factor and it's how old you are and that's because of the underlying Biology that creates a change in our physiology that is permissive for all of those diseases to happen where did your Research begin in this area.
Why Matt got into the biology of aging (08:45)
I actually got started thinking about and Actively studying the biology of aging as a graduate student. So this was back in I guess it was 1998 I was a first-year graduate student at MIT and I went to MIT thinking I was going to do structural biology x-ray Anesthesiography something like that and I heard a talk by a professor there Lenny guarantee on The research that his lab had started doing really only a few years before I got there where they were taking a genetic Molecular biology approach to try to understand the mechanisms of aging and at that time They were working in a single-celled organism budding yeast called saccharomyces cerevisiae, but to this day I still don't know why that resonated with me But I have this very vivid memory of sitting in this lecture hall hearing Lenny talk about Trying to understand the mechanisms of aging using genetics and molecular biology and biochemistry and I was hooked I never ever thought about studying something as complicated as aging and it it just it captured me And so I went and I talked to Lenny and I ended up joining his lab and I've been working on this problem You know in one way shape or form since then now you at one point seem to have had a fork in the road Mathematics we're talking about this before We started recording and biology Did you have any misgivings about?
Mathematics vs. biology (09:54)
veering into the sphere of biology So I don't think I ever had any misgivings But first of all I'll say I've had many forks in the road and honestly at that age and maybe to some extent still in my life if anything I under analyze decisions, so I don't think I had any misgivings So what I'll say is I got my undergraduate degree at a college called Western, Washington University, which is about 90 miles north of Seattle. So it's a smaller University mostly undergrads no PhD students. Maybe a few master students and I went there Intending to major in biochemistry and it was probably the first summer there I had a math professor who was fantastic who kind of pulled me aside and you know, he was like you're really good at math I think you should take my proofs class over the summer and I never actually done a formal mathematical proof before that But I ended up taking the class loving it and then he's like you should major in math And so I ended up getting a degree in mathematics and a degree in biochemistry when I graduated from my undergrad But I don't think I ever Seriously thought about a career in Mathematics, I think you know, I do wonder sometimes what would have been different if I'd gone down that road But I think I was always drawn towards Biology in some shape biomedical research. I think I wanted to have an impact on Human health not that you can't have an impact in lots of other fields But I think I was drawn to that and so I never really seriously considered applying to graduate school in a mathematical application and only applied to Biology biochemistry I did apply to one chemistry program as well. Let's flash forward to current day We're gonna do a lot of this bouncing around you're wearing a shirt. It says dog aging project on it What is the dog aging project?
The Dog Aging Project (11:54)
So the dog aging project is? the largest study longitudinal study of aging in I think any animal but it's all in companion dogs and so this is a National study across the United States now of more than 40,000 companion dogs living with their owners When I say companion dogs, I mean pet dogs living with their owners to really try to understand What are the most important genetic and environmental factors that influence? aging biological aging in dogs with the recognition that Most of the mechanisms of aging that happen in dogs also happen in people and so this will be relevant For both companion dogs and also for people and I would say there are really two parts to the dog aging project the first part Which is the largest is what we call a longitudinal study of aging So completely observational all of the dogs that are in the longitudinal component We're not asking the owners to do anything different than they normally would we are following those dogs over time to try to learn as much as we can about What are the factors that cause them to age the way they do develop diseases that they do as they get older? And then there's a much smaller Clinical trial which is really aimed at testing whether or not we can Have an impact on the biological aging process in companion dogs to slow aging maybe even reverse Functionally some aspects of aging help dogs live longer healthier lives and we're testing a drug called rapamycin Which I'm sure we'll talk more about in that clinical trial I kind of think of this as having two parts the longitudinal study is let's Understand as much as we can about aging the clinical trial is let's do something about it and I am very much In the camp of let's do something about it yes, we will talk quite a bit more about rapamycin maybe very soon in this conversation and For people listening my hope and intention with this conversation is to help listeners to better develop Scientific literacy to the extent that you can separate some fact from fiction with respect to longevity Lifespan and healthspan, so let's underline this word healthspan for a moment and I'm gonna frontload this so please forgive me. I was planning on maybe asking this later Could you please describe your experience with frozen shoulder?
Defining healthspan and are all years created equal? (14:16)
Sure, so should I define healthspan first, or do you want to come back to that? Well, I thought they might they might tie in so however you would like to tackle it So the first thing I would say is it's interesting because this term healthspan is pretty new even in my field ten years ago most people were talking about healthspan and I think it's sort of become popular because it resonates with people and what we mean by healthspan is The period of your life that is spent in what we would consider good health And I think there are different ways you could define that and maybe different people would define good health slightly differently But conceptually I think this makes a lot of sense, right? We all know we go through our lives for most people when you're young You are experiencing good health you are functioning well, and as you get older that health declines that function declines You know I often will say that that I am damaged 51 year old and what I mean by that is that Functionally, I'm in pretty good health for being 51, but functionally I'm nowhere near where I was when I was 21 and I think we all experience that so healthspan is a Concept to try to track how much of your life is spent in good health now The reason why I'm going into a little bit of detail on this is I think it's really important to recognize that healthspan is not quantitative we don't have a way to Quantitatively measure healthspan in some ways It's a you know You you know it when you see it kind of thing or when you don't so I want to make sure that people don't get confused about When claims are made that drug X extends healthspan You have to be a little bit careful because if it's something you can't quantify You really shouldn't make a claim that you have changed it scientifically.
Frozen shoulder, rapamycin, and sterility. (16:05)
So I think that's important. Okay, so frozen shoulder How does that come into play? So when I was I was probably 47 or 48 I Started having a lot of pain in my shoulder and I you know, I'm I'm pretty active I do resistance training fairly regularly. I play softball when it's softball season play basketball and stuff like that So it was a gradual thing where I noticed that I was having more and more pain in my right shoulder And I really noticed it during softball season, but it was a weird like I've had injuries here and there But it was a weird kind of pain where you know If I was in the gym Trying to do a bench press or something like that The pain was most severe when I started and then it kind of gradually got better as I as I was going I'd never really had an injury like that before I had no idea what it was I'd never heard of frozen shoulder at this point But when it really impacted my healthspan or at least I would say my quality of life was one day when my son and I Went across the street to the park near our house and I tried throwing the football to him and I just couldn't do it I did like two throws and I had to tell my kid, you know, Jayce. I'm really sorry I just can't do it. It hurts too much and for me I mean, I think you know, obviously we all have life experiences and many people have had experiences that were worse than that for sure But for me that was kind of an emotional moment. I was at a point in my life where I had a physical Problem and I couldn't go out and throw a ball with my kid and I'll also say I'm trying to get better at this but I'm a Somewhat stereotypical guy and that I won't go to the doctor until I have to go to the doctor So that was the moment where I finally was like, okay, I have to get this fixed. So I went to my General practitioner. He wanted me to go to physical therapy I went to physical therapy for I don't know maybe six seven weeks and it was just making things worse So I went back to him and I at this time I thought I had a torn rotator cuff Like I had convinced myself that that's what was wrong So I went back to him and I'm like physical therapy is not helping get me in to see a specialist I need to get this fixed and I was actually hoping that I would go to the specialist He would say okay, you have a torn rotator cuff We need to get you to have surgery because again, I just wanted it done. I wanted it fixed So finally I go to see the specialist and within five minutes He's like you don't have a torn rotator cuff You have frozen shoulder and he called it adhesive capsulitis, which again I hadn't heard of before And he explained to me that it's fairly common in people in my sort of demographic group more common in women than men But but it happens in lots of men and it's an inflammation of the shoulder capsule His recommendation was he said I can give you a shot, but I don't recommend it It doesn't really last that long and that can create problems with the cartilage like a corticosteroid shot. Exactly. Yeah So I think you should just go back to physical therapy and you know for some people it goes away in about a year and That was not what I wanted to hear, right? like a Year, that's not what I came back exactly. So I was pretty depressed shortly I don't I this is another part of my personal makeup I think I don't stay depressed but I was pretty for me I was pretty depressed right after this and I vividly remember and I was angry too and I'm sitting in the car just like this sucks And I'm thinking to myself. Okay, you know, this is an age-related Inflammatory condition this is exactly what I study it probably should have occurred to me before then but I finally had that realization and So then I thought to myself well I know Some things that might help and so maybe I can treat myself and that's what I ended up doing So again sure we'll talk more about rapamycin, but that's the drug that I if I had to pick one intervention That's the one that I have focused on the most throughout my career And one of the things rapamycin is quite good at is reducing age-related Sterile inflammation and so I thought maybe this would be a case where rapamycin would be helpful So I started taking rapamycin about two weeks in I was pretty convinced that it was having an effect because I got about I'd say Half my range of motion back and by the end of the ten weeks So I decided I was gonna try ten weeks and we can talk about that Why ten weeks if you want to but that's sort of what I what I had decided by the end of the ten weeks I was back the pain was gone and I had probably 90% of range of motion back and it hasn't come back So look, I'm a scientist. I believe in placebo effect. It is real This was so painful and for me so limiting on what I could do. I just I don't think it was placebo effect I think it probably was the rapamycin.
Why rapamycin is a game changer among drugs targeting aging (20:21)
So let's talk a Lot more about rapamycin. What is Rapamycin, let's begin with the Primary or initial indication for which it is used or maybe we don't want to start there, but let's just broadly Explain what rapamycin is and now also just for a definition in terms you said sterile inflammation Does that simply refer to a chronic inflammation not caused by infection? That's right Yeah, and actually I think maybe that's worth digressing on for just a minute because I think you know A lot of times you'll hear people say that our immune system declines with age and I'm sure we've all heard that during kovat Right. We know that the elderly were most susceptible to severe outcomes from kovat. So you'll hear people say that that's actually not true It's not correct. That's half the story. So the ability of our immune system to Respond to pathogens declines with age or to respond to a vaccine declines with age at the same time our immune system is Responding inappropriately to a bunch of stuff that it shouldn't be responding to that's the sterile inflammation that I'm referring to and you could broadly Group that as autoimmunity. There are a lot of disorders that we all know about that are sort of formal autoimmune disorders but I think a lot of the chronic aches and pains that go along with aging are a Milder form of autoimmunity that are driven by this sterile inflammation But there's also a term that has been popularized in the field called Inflammaging, inflammaging to refer to this increase in sterile inflammation that goes along with aging But I do think this is it's an important point immune function both declines and increases So it's responding to stuff it shouldn't be responding to and it stops doing its job the way that it's supposed to and those two things Are connected part of the reason why our immune system can't respond to things like coronavirus or a coronavirus Vaccine is because it's spending too much time Doing this autoimmune stuff and that inhibits the response that you want So rapamycin it turns out is pretty potent. It seems at blunting that sterile inflammation it may also have impacts on the Response of the immune system to pathogens and we can talk more about that That's one of the concerns that people have with rapamycin But it seems quite potent to turning down this sterile inflammation and what's been seen in mice for sure And there's some evidence for this in people as well Is that if you give six weeks of rapamycin to a mouse? You can actually and then you stop the treatment you can actually cause that aged immune system to function Like a young immune system and it fully responds to a vaccine Whereas the aged immune system that's never seen rapamycin doesn't respond to a vaccine What and I'm gonna ask a lot of basic questions in part because on one hand I probably don't know the answers and then I'll also act as stand-in for the audience what exactly or even approximately happens even if it's Theory at this point to someone as they age that causes this Let's just say double-edged sword with immune system changes where on one hand they're under reacting But they're under reacting in a sense because they're overreacting somewhere else What are the processes? Responsible for that so I will give you kind of what we think right now I will say it's not fully known and I'll also make a disclaimer. I am NOT an immunologist I have tried several times to learn enough immunology to be credible and I failed miserably every time It's like a completely different language I have a lot of respect for immunologists, but I really wish they'd learn how to talk to regular scientists. Let alone regular people But but I'll give you my understanding of the immunology here So so there's probably a couple of things going on one is that you know We are from birth constantly exposed to all sorts of stuff that our immune system Reacts to write all sorts of pathogens and even things that aren't necessarily pathogens our immune system will respond to I think part of it Is just the burden of that Years and years and years of the immune system responding to all sorts of different stimuli That it becomes overactive Towards even self antigens, right? And that's where the autoimmunity comes in I think from the context of aging biology the mechanism that has been best worked out is in the area of what are called senescent cells, so these are cells that Accumulate as we age they don't die so there's a there's a mechanism called apoptosis or some people say apoptosis where cells can undergo program death or Death in response to damage and that's an anti-cancer mechanism, right?
How do senescent cells fit into aging? (24:40)
You want if cells are damaged Do you want them to die so they don't become cancer? Senescent cells are a different off-ramp that damaged cells can take they don't die So they stay around but they stop dividing and so they won't become cancer the problem with senescent cells Is that they give off a whole bunch of signals that hyper activate the immune system or target the immune system? These are called inflammatory cytokines. It's a process called the SASP SASP or senescence associated secretory phenotype. These are all these signals the senescent cells that accumulate as we get older So there's more and more of them as we get older They give off these signals which tell the immune system to go crazy basically and so that probably from a molecular Viewpoint is I think most people would say maybe the primary reason why we have this chronic inflammation with age and There are strategies people are taking there are these class of molecules called senolytics Which are molecules that are designed to go kill senescent cells right with the idea that a lessening senescent cells like anxiolytic This is that the basic idea Yeah, well, right. So the idea is with age right? We have this accumulation of senescent cells They don't seem as far as we know they're not doing anything good so if we can target molecules that will specifically kill those cells, that'll be Beneficial and the mechanisms are complicated probably beyond probably beyond the detail that we want to get into here And I mean this this idea has caught fire in the field, right? It's a really sexy idea, right? We've got these misbehaving cells They're good for nothing do nothing cells that just kind of hang out and convince the other cells to do bad stuff So if we could get rid of them, that'd be a good thing. Turns out it's probably not that easy not surprisingly biology is always more complicated, but Conceptually, it's a really nice idea And so lots of people are working on this now this ties back to rapamycin because what rapamycin does it doesn't kill the senescent cells But it basically shuts off this SAS the inflammatory signals So it's like you're not killing the good-for-nothings that are creating the trouble. You're just putting a gag on them They can't talk anymore and rapamycin seems really potent at doing that and then one of the consequences of that is it? Seems to reboot the immune system and then the immune system is actually pretty good at clearing senescent cells So it may actually indirectly also help clear senescent cells. So that's a little bit speculative that's kind of my own personal idea that there's some evidence for and I think you know, if I'm right, which I Sometimes then we'll get more data for that But it makes it makes sense but but definitely lots and lots of people have shown that rapamycin can turn off the inflammatory Signals that the senescent cells are putting out. So that was my rationale for the whole going back to the frozen shoulder I sort of had you know I did enough reading on on what it was to recognize that it was Inflammation of the shoulder capsule not knowing why some people get it and some people don't but it made sense to me that it was tied into this chronic inflammatory state and We had already at that time data from my lab that in mice We could knock down that chronic inflammation in a few different tissues with rapamycin very potently And so I thought there's a chance might work. Why not better than waiting a year? Yeah, I mean one of the best I've made a lot of bad decisions in my life Fortunately not too many really bad ones, but that was a good one And I mean again this this gets back to what you were how we originally got on this which is this idea of health span I think that we are sort of trained at least as scientists and medical Professionals to think of health only in the context of disease, right? But I would say most people Their decline in health as they get older starts way before they are ever diagnosed with kidney disease or heart disease or Emphysema or whatever right pick your favorite age-related disease We all have these chronic aches and pains and declines in function that have a real impact on our quality of life and so I think those are maybe as Important maybe more important than the individual diseases that could be impacted by targeting this biology of aging So rapamycin just to double click on that word for a quick second and you can please correct me if I get this wrong But for those people interested in more we will talk Additionally about rapamycin in this conversation, but had a conversation on Easter Island also known as rapid I'm jealous that's on my bucket list years and years ago with a number of scientists as well as dr Peter Tia who made the introduction between us.
Other applications of rapamycin benefiting humans (28:33)
So if you want to learn more about the origin story of Rapamycin certainly you can listen to that conversation What is rapamycin most commonly used for these days? Rapamycin was first approved by the FDA I think in 1999 so it's been clinically used for a while now to prevent organ transplant rejection and I think it was first in kidney transplant patients But it is used for some other transplants as well. So that's how it's been used most in Clinical practice it is also used for some some types of cancer are particularly responsive to rapamycin There are a few more rare disorders that are known to be caused by Reactivation of mTOR which we haven't talked about yet, but mTOR is the protein that rapamycin inhibits and so it's used clinically there It's also used in or has been used in cardiac stents to prevent regrowth of cells over the stents So mostly organ transplant but a few other less widely known uses I was working because we may or may not know someone who has mTOR on his license plate How many times do you think? The term mTOR has been uttered on the drive the podcast that Peter Tia Hosts, I mean, it's got to be in the thousands. Yeah, I was I was gonna say, you know somewhere between five and ten thousand But that may be a low guess Why ten weeks to come back?
Rapamycin impact on people, including periodontal disease. (30:59)
Yeah to your story honestly, that was based off of studies that we and others have done in mice where we know that It seems like between four and ten weeks or twelve weeks You can definitely get a lot of benefits from rapamycin treatment and it might be worth at some point Talking about what those are. It's pretty striking how wide in terms of tissue these these effects that people see are Pat Let's let's use the power of now. No, don't like the present. So the first thing I would say is, you know If you had asked me Ten maybe fifteen years ago the interventions that we are studying on the biology of aging How are they going to work? Are they going to slow aging or are they actually going to potentially? Do more than just slow the decline I would have said we're gonna slow the decline I didn't think that we would be able to find things that could actually make Organs and tissues functionally better, but we know that's the case with rapamycin and with some other interventions So in mice if you treat old mice with rapamycin for between four and twelve weeks And I'm giving it that's a pretty big range, but that's because different people have done different experimental paradigms. You can definitely see reversal of functional declines in The immune system so the immune system will respond to vaccines better After treatment with rapamycin the aged immune system. Let me clarify that in the heart So the aged heart functions better after rapamycin treatment in the oral cavity That's work from my lab that was done by Jonathan on when he was a graduate student with me. You can reverse periodontal disease Eight weeks of rapamycin treatment reverse periodontal disease what type of periodontal disease? So periodontal disease your train of thought, but I'm curious Yes, so periodontal having just gone to the dentist for the first time in three years after a coven, right? So in people and again, I'm not a dentist. I haven't spent as much time trying to become a dentist. Yeah My understanding is that in people periodontal disease is usually diagnosed by a few clinically defining features The most important one is probably bone loss around the teeth So we all have bone around our teeth and in everybody with age that recedes with age you lose bone around the teeth gingival inflammation So gingival inflammation alone is gingivitis, but that's one of the features of periodontal disease and then pathological changes in the oral microbiome So those are the things that we looked at in mice actually take a step back The first thing we did was just ask do mice develop periodontal disease with age because people hadn't done that previously and it turns out They do they get those three Defining features of periodontal disease and what we saw was that eight weeks of treatment with rapamycin Reverted the oral microbiome back to something that looks more like a youthful microbiome dramatically reduced gingival inflammation and Actually regrew bone around the teeth. Yeah wild. Yeah, it's amazing Yeah, I'm gonna keep interrupting because this this I want to hook on to it's so interesting the regrowth of Bone tissue do you think there's a possibility that is a it is a Non-selective growth agonist for other tissues and I ask because you see for instance in some cases bodybuilders who have used super Physiological doses of growth hormone for a long period of time and they look like they're six to nine months pregnant Yeah at rest.
Could rapamycin treatment cause overproliferation of tissues? (33:58)
I mean because their viscera have grown. Yeah any thoughts I'm not sure exactly what you're asking about rapamycin. Is there a risk that it grows a wide spectrum of tissue It's interesting. So people who know about rapamycin and mTOR a lot actually have the reverse concern So it turns out mTOR again the the protein that rapamycin inhibits Promotes growth and so bodybuilders often will try to hyper activate mTOR You'll see these in fact, it's funny because some of the bodybuilder mixes of like leucine and other amino acids is like, you know mTOR activator on the bottle, right So they actually try to activate mTOR so most people would think if you inhibit mTOR You're actually going to reduce growth and actually potentially lead to something like sarcopenia turns out that's not the case That's another tissue where it's sort of amazing sarcopenia always age-related muscle loss or just muscle loss. That's a good question I'm not I'm not a muscle person either. I don't know what I do, but I know what I don't do Well, I think you practice your your muscle purse, yeah But mostly I think about it in the context of aging yeah age-related muscle loss So I don't know of any reason to be worried that rapamycin would cause over proliferation of bone or other types of tissue But you know, this is pretty new right and I think before we did these experiments Most people would have thought if anything we would expect to see a loss of bone Yeah, and but in reality what we saw was the reverse and I think this may come back to this inflammatory state So this is the thing right when you have a chronic Inflammatory state in your tissues that actually impairs the ability of stem cells to do it what they normally would do And I also think that's probably the biggest reason why rapamycin can improve function in some tissues with age because what you're really doing Is you're knocking down that chronic inflammatory state and then the stem cells are like, oh wow more resources go back and do my job Yeah, so I think that might be what what's happening and we have some molecular Understanding of what's going on in the bone. But yeah, I do think the point you raised is a good one that we do want To watch out with not just rapamycin, but any intervention we're using to target the biology of aging We do want to watch out for the possibility that we might take these Systems that are functioning at a suboptimal level and instead of bringing them back to optimal we bring it too far So I think that's always a something we want to pay attention to the other place that this hasn't really gotten into the public Awareness yet, but I was just at the reproductive aging conference a couple of weeks ago This is a new area of aging biology. That's super fascinating and it's mostly focused on female reproductive aging. I Saw probably three different talks on rapamycin rejuvenating ovarian function in my Really really fast is interest and my good friend you shin sue and zev williams at Columbia are actually starting a clinical trial of rapamycin in Women who are undergoing premature ovarian failure So I think we may get some data on this You know in the not-too-distant future and people and in parallel John John on the former graduate student of mine I mentioned he's now an assistant professor at the University of Washington Is starting a clinical trial for periodontal disease with rapamycin?
New studies in 4 areas of rejuvenation, dog and human. (36:49)
So I'm pretty excited to see where this goes and and hopefully we'll get some data and people in the near future Why cycle off of rapamycin aside from is there are there reasons aside from the? Experimental designs that have been published right second understand why yeah, why not just keep taking it Why not keep take yeah, and lots of people have done that in mice so in mice people have given rapamycin From a very young age all the way through to old age and death Some people have started in middle age and then some people have done these transient treatments that I mentioned so in mice You get most of the benefit in terms of lifespan at least from Starting in middle age and going till the end of life and even the experiment we did was a 12-week Transient treatment looks like you get most of the benefits for lifespan Maybe not quite as big but you get most of the benefits from just a single 12-week treatment now mice Obviously age a lot faster than people I don't have no idea that that would have anything to do with 12 weeks and people but but that's the observation So then the question is why wouldn't you want to do a continuous treatment so most?
Personal Applications And Criticisms Of Aging Studies
Reasons cycle treatment: Getting the best of both worlds? (37:45)
Physicians who know about rapamycin first of all it's usually called sirolimus in the clinical world So it's the same drug, but two different names. How do you spell that I've never heard that I are oh Li mu s Sirolimus is how I say it Sirolimus is how people who know what they're talking about say it if you are a physician That's the name you would know it under or rapamune Which is the generic sounds like the name of a scribe from Lord of the Rings and I continue yeah So most physicians if they know anything about rap alive rapamycin or now I'm gonna say rap alignment Rapamycin or a sirolimus they are gonna know about it in the context of organ transplant patients so in organ transplant patients They've been taking high doses of the drugs Usually with strong immune suppressants and in that context there are side effects associated with rapamycin So the concern of course the reason why you might not want to take rapamycin continuously is that maybe the risk of side effects? Goes up the longer you take it, so that would be one rationale for not taking it continuously And that's more or less my rationale I know lots of people who take rapamycin continuously and have not experienced side effects, but that's sort of my Reasoning the first thing is I'm very much a realist about this. I recognize this as self experimentation We don't have clinical trials. We don't know with any real quantitative Estimate of risk reward I know enough that I believe that the risk reward ratio is strongly favoring reward Especially when I was experiencing frozen shoulder, but even still you know I take rapamycin off and on but we don't really know And so my view was in the animals and especially going back to this chronic inflammation model the idea that Periodically knocking down that chronic inflammation, and then it'll take a while for it to come back Makes sense and so that's really the rationale that I started with because I recognize that this is unknown territory That it is experimentation. I don't have a great reason to think that continuous would be better than Repeated cycles dose is still a little bit of a guess, so I don't worry too much about being very precise and all of that Just a quick thanks to one of our sponsors, and we'll be right back to the show this episode is brought to you by athletic greens I get asked all the time what I would take if I could only take one supplement the answer is invariably Ag1 by athletic greens if you're traveling if you're just busy If you're not sure if your meals where they should be it covers your bases with approximately 75 vitamins Minerals and whole foods source ingredients you'll be hard-pressed to find a more nutrient-dense formula on the market It has a multivitamin multimineral greens complex probiotics and prebiotics for gut health and immunity formula Digestive enzymes and adaptogens you get the idea right now athletic greens is giving my audience a special offer on top of their all-in-one Formula which is a free vitamin D supplement and five free travel packs with your first Subscription purchase many of us are deficient in vitamin D I found that true for myself which is usually produced in our bodies from
In so much as you can, what are you doing personally relative to rapalogs? (41:00)
sun exposure So adding a vitamin D supplement to your daily routine is a great option for additional immune support support your immunity gut health and energy by visiting athletic greens Comm slash Tim you'll receive up to a year's supply of vitamin D and five free travel packs with your subscription again That's athletic greens comm slash Tim Let me revert back to the dog aging project for a second you mentioned the clinical study side and I would love for you to describe the Hypothesis going into that what is the and I hesitate use the word hope right but with the intervention of rapamycin What might you see based on?
The Dog Aging Project. (42:22)
previous data or Studies so let me take a step back because I think it's useful to first just briefly talk about how this idea even came about great because really in my mind I think the first time I really thought of the idea of doing a clinical trial in dogs was It's going on ten years ago. Now. I think it was probably 2013 and Daniel promisela who's co-director of the dog aging project and Kate Creevy who's our chief veterinary officer had been thinking about the longitudinal study Well before this so I actually was actually in conversations with them that got me thinking about companion dogs Living in the human environment as a an animal that we could actually study and learn about the biology of aging and I'm a dog person I've always had dogs. And so the idea when it's solidified in my mind, there's really no reason why These interventions that we can increase lifespan and healthspan in mice. They're gonna work in dogs Like I am I don't know that all of them are gonna work I don't know rapamycin is gonna work, but I am 100% rock-solid confident But some of them are gonna work and being a dog guy and wanting my dog to live longer when that light bulb went off in my head, I was like This goddamn has to happen. Yeah, right This has to happen. And so that was really what got me on the path of them thinking. Okay, how do we do it? How do we actually? How do we start that process? How do we actually test whether or not an Intervention I hadn't settled on rapamycin at that time would have this effect in dogs And so that was the process of going through how do you set up a clinical trial? One thing to consider is companion dogs very much like people's children So you kind of think about a clinical trial the way you would a pediatric clinical trial You really have to be sure whatever intervention you're using isn't gonna kill somebody's dog or harm somebody's dog so these are all the things that I started thinking about and I settled on rapamycin because There was enough evidence at that point to convince me that it could be done safely that was really the only concern with rapamycin based on the side effects that I talked about in organ transplant patients that it could be done safely and Because it was our best bet for the interventions that we knew about then and I would say still now For being likely to have an effect on lifespan and healthspan for the reasons that we've sort of already gotten into So what might we expect based on what we know in mice? So I talked about some of the tissues where rapamycin makes things better There are many other tissues where it hasn't really been looked at in that context of better But where at least if you give it lifelong The declines are delayed at a minimum we can say that so that's true in brain.
What could we expect on dogs? (45:03)
It's true in kidney It's true in liver. May I pause for a second? Yeah, what type of degeneration or changes are delayed or reversed in the brain This has been studied both in the context of normal aging and in mouse models of Alzheimer's disease and other neurodegenerative diseases in every case you see Improvements in function. So these are behavioral tests in mice. There are these may water maze tests things like that, right? So to the extent that they are actually telling us what we think they're telling us about cognition You see improvements in the rapamycin treated mice versus the control mice performance task performance based. Definitely those functional measures are the ones that I put the most faith in right? I think sure you want to see changes in pathology and molecular biomarkers and things like that I don't care if the biomarker changes if it doesn't make it function better though So that's why I start there, but people have done lots of studies looking at cerebral blood flow So that's one model that's been put forth there's decreases in neuroinflammation as we would expect given the effect of rapamycin on inflammation and increases in Metabolic function or mitochondrial function in the brain. So there are plausible molecular mechanisms by which rapamycin could be having these effects and that's pretty much true in the other tissues where rapamycin has been shown to have effects is a lot of people have been studying this and made I think reasonable Models at a molecular level for how rapamycin is acting so I'll just I'll cut it short and just say pretty much every tissue where People have looked you can find evidence that Function has been at least preserved the one that might be worth commenting on briefly and coming back to because we touched on it is muscle So early on there was a lot of concern I think particularly among muscle biologists that rapamycin would increase sarcopenia or Enhance muscle loss with aging and make things worse and that's because it's known in muscle biology that mTOR Promotes muscle growth or at least it's required for protein synthesis, which is part of muscle growth so the Conventional wisdom was that when you inhibit mTOR that would lead to a decrease in muscle mass muscle function Several studies now in both mice and rats have shown it's exactly the opposite you maintain muscle function better with age When the mice or the rats are given rapamycin now dose is probably important So I do think if you were to push the dose too far, you know, you might impair muscle growth or muscle maintenance But if the doses that also extend lifespan and have all these other effects Muscle is actually functioning better in old animals than in control animals. And this is why I constantly I Constantly tell the people in my lab and and other scientists. You've got to do the experiment you cannot go into it thinking that you know the answer and not do the experiment because your Dogmatic belief says this is how it's going to work. You've got to do the experiment so based on the Mice data, let's just say Lifespan in terms of percentage. Yeah increase in this case. What might be the the range? I think the upper side for what's been shown in mice so far with rapamycin is about 25% increase in in lifespan I do and I mean that's certainly possible in dogs I would say if I had to guess I would guess it's not going to be that the Magnitude of effect on a percent basis is not going to be as big and longer-lived animals. That's just a guess I don't have any data to support that which you know might mean that the the the magnitude of effect in people is going to be even smaller because people are much longer lived than The dogs are and much longer lived than mice are so but it could be as much as 25% So, you know if you're talking about a large dog that maybe would normally live to be 14 years old You're talking another three years study worth doing and I say that as I'm looking around you to My dog Molly seven years of age laying on the floor and The function matters right? I mean the function really matters. Absolutely I think most people would agree that the function matters more than the absolute lifespan I think almost everybody says if you'd ask them, you know, would you want to live longer? They're like no not if I'm gonna live longer in a decrepit state Now, is it fair to say that that is one of the valid criticisms of at least certain forms of say caloric restriction?
Criticisms of adding years to life (49:40)
Well, I don't know maybe I mean, I wouldn't necessarily pick on caloric restriction I think there's evidence that at least in mice that caloric restriction can maintain function later in life as well Now you could make an argument quality of life for sure I would pick on caloric restriction then in people but I think the general question is that a valid concern in targeting the biology of aging I would say it is and it isn't so Nothing that I have ever seen and I've seen a lot of things that extend lifespan Nothing has ever Convincingly extended the Bad part of life the decrepit state. There's a little bit of debate in the C. Elegance field about that But I think that's these are people arguing over silly stuff. I've never seen anything that does that it's C. Elegance system It's a nematode worm. It is right nematode worm. Yeah, even there. I think it's a it's a semantic argument Not a real argument, but it's certainly in mammals nothing that extends lifespan Makes the end period only extends the end period of life I think it's a legitimate question whether some of these interventions might proportionately extend lifespan where you're Proportionately extending healthspan, but you also have an absolute sense to have a longer period of decline That is hard to really completely resolve I would say things like rapamycin and caloric restriction which those are the two most potent interventions We've got right now really do seem in mice to push the declines in function and diseases back later into life So you really have disproportionately extended healthspan compared to lifespan, but again, that's my interpretation of the data But it's a hard case to make quantitatively when you were Considering different candidates as Interventions for this dog aging project rapamycin that ended up being the top pick What would have been the second and third place? Finishers, yeah, the first thing I'd say is I think if I had like a boatload of money and I could test ten interventions I would not try to make the decision myself.
Additional small molecules that David is interested in and would like to test on dogs (51:30)
So I'll give you my list I'm not dodging the question but I would get a bunch of my Best friends who I also respect their science together and sit down and talk about it because I certainly Think that we could come to a better collective decision, but I think the place where I would start are with interventions that Robustly and reproducibly extend lifespan in mice. I think you'd have to take a look at caloric restriction I think there would be some concerns about caloric restriction in companion dogs And you know also the logistics of wood owners actually do that So I probably wouldn't include caloric restriction But you would think about other forms of caloric restriction and maybe that's a topic we want to talk about as well like pharmacological interventions Intermittent fasting, you know time-restricted feeding things like that So other nutritional interventions that maybe aren't as severe or maybe not as hard for owners to adhere to. Yeah Yeah, but then there are a series of small molecules that have come out of something called the interventions testing program. So this is a National Institute on Aging funded program To do what the name says test Interventions in mice for the ability to extend lifespan and this is kind of the gold standard So there are lots of labs including mine that are out there that do lifespan experiments But this is kind of the gold standard because it's got built-in triplicate replication So the studies all get done at three different sites and they have shown a handful of Small molecules that extend lifespan in mice interestingly and this is something people don't really understand Many of them only extend lifespan in one sex or the other in mice. Yeah, and it tends to favor males so more drugs extend lifespan in males than in some it will break even with the To the females, yeah, so nobody understands that that's another area that people are really interested in So rapamycin has been shown repeatedly by the interventions testing program to extend lifespan in both males and females And it's the biggest effect, but there are other drugs like a carbose which is an anti diabetic drug That is in males at least close to rapamycin in terms of the magnitude of effect 17 alpha estradiol, which is a sex hormone extends lifespan in males NDGA is another one. So there are probably six or seven Small molecules that have come out of that program that would make sense to think about testing in dogs again Because like I said, this is almost like doing a pediatric clinical trial first thing is what do we know about this molecule in dogs? Can it be done safely and then there are a couple of others that I would put on the shortlist? Not because they have extended lifespan by the ITP But because there's so much buzz around them in the field and because there is some evidence that they can Extend healthspan and two that I think would fit in that category are metformin, which is the most commonly prescribed Diabetic drug in the world probably most people listening to your podcast have heard of metformin It's gotten a lot of attention for its potential effects on longevity and near barzillai Einstein has been championing a human clinical trial called tame which stands for targeting aging with Metformin and if you want to talk about that, I'm happy to but I think because we know a lot about metformin and its effects on Metabolic health and it's been talked about so much in the field that probably makes sense to look at NAD precursors is the other class of molecules I would put in that bucket Actually and nicotinamide riboside, which is an NAD precursor did not extend lifespan by the ITP but there's a lot of evidence that you can have beneficial effects on metabolic health and health in general and NAD precursors are almost certain to be safe so again coming back to the you know doing this in dogs and then there's a couple of others that I am Interested in that are more recent one is alpha ketoglutarate Which is a natural product metabolite that a lot of people are thinking about now There's one study that showed a small lifespan extension in mice and the other is a molecule There's two that actually are thought to target autophagy or mitophagy mitochondrial autophagy One is called spermidine and the other is called urolithin a and so I would take a close look at those but you know again That's a short list and we could you know If I sat down with my friends for an hour, we could probably come up with an equal number of other things to kind of Think about okay Let me you asked. Oh, of course I did. That's my job So I want to take a closer look at a few of these especially a number that I don't recognize Actually before we do that.
Exploration Of Potential Life Extension Substances
I know you talk to your smart friends But since they are your close friends, presumably you've probably spoken about this before so let's just say you were benevolent dictator of Targeting aging clinical trials program and you had to pick one of these aside from rapamycin Not holding you to it clearly. This is just a thought exercise, but where would you lean and actually, you know what? I'm gonna take metformin off the list just to make it easier. Okay, I wouldn't have gone with metformin. Anyways, I would Probably go with alpha-ketoglutarate, but I would Take a close look at your oleithin a and spermidine. Can you tell me more about? Your oleithin a and spermidine. Yeah, and what those are used for currently So spermidine is found in in food, right? So we get spermidine in our diet, but it's usually at a pretty low level So spermidine again, there are several labs that have worked on this. I'm unfortunately, I can't remember the the Japanese scientists We'll find a few and we can put it in the yeah who has shown correlations between dietary consumption of spermidine and mortality and other health outcomes in people and then Frank Mideo Was the first to really start studying this in the basic biology of aging site and has shown that you can extend Lifespan in a few different organisms. I can't remember if there's a really strong lifespan I think there's a lifespan study in mice that looks pretty good but certainly a bunch of healthspan measures in mice that are treated with spermidine and The mechanism is through they think through enhancing autophagy which is this mTOR regulated process so rapamycin also turns up autophagy and You know some people will kind of refer to it as the recycling center of the cell and one way to think about it is we know that as we age there's an accumulation of a bunch of damaged stuff and Autophagy is a mechanism to help Clear that damage and then recycle the components so they can be used to build new functional machines So spermidine is an autophagy booster and there are a bunch of companies actually trying to make pharmacological autophagy boosters So that's the mechanism for spermidine and then your oleithin a is also an autophagy booster I don't know as much about the source of your oleithin a it is a natural product but I don't know as much about the source, but it seems to preferentially boost a specific type of autophagy called mitophagy or Mitochondrial autophagy and so the idea is there that you're kind of restoring metabolic function by Breaking down the damaged mitochondria and making new mitochondria and that has been shown to extend lifespan in it started in worms And I think there's a mouse study, but there's also now been At least one clinical trial which I this is new I haven't really had a chance to dive into the clinical trial in depth. I'm kind of waiting for Peter Attia to do that for me Tell me what's wrong with it. No, I'm just kidding. But my quick glance at the trial looked pretty interesting It looked like there may have been some improvements in muscle function in older people taking your oleithin a which is what we would expect If you're really enhancing mitophagy that study was of course funded by the company that's trying to develop this and sell it So, you know, there are some conflicts of interest there, but I think companies can fund and do good clinical trials I just haven't a chance to dive into it and really evaluate it. What is the function or significance of 17 alpha Estradiol, I don't think people really know the mechanism there at this point There are a lot of things that have been proposed and I think that's really a mystery right now how it's working to extend is it working? Selectively in males. Yes. Okay. Yeah. Yeah. Yeah That's one of the ones where it's only in only in males and whether it's having feminizing effects I don't know that people look closely about or a cardio protective effect this although in mice most people would say that a Significant fraction of mice die from cancer depending on the strain background.
17 alpha-Estradiol. (59:48)
It's probably between like 60 and 90 percent dive cancer die of cancer so and most people would say that Vascular disease at least is not a significant component of death in mice Maybe maybe true cardiac disease in a small fraction interestingly the same thing's true in dogs about well Really about all certainly vascular disease not a big cause of death cancer a much greater cause of death although I Have to be precise Euthanasia is the leading cause of death in dogs But usually people will euthanize their dogs for a reason and cancer is one of the big killers in that sense So I don't think most people would immediately think that an intervention that Prevents vascular disease or even heart disease would have a big effect on mouse lifespan if it wasn't also impacting Cancer and potentially also other age-related disease that makes sense. So I'd love to visit two more and I'll actually Mention the one will do second which is the NAD Precursors and I want to ask about this specifically because it has become very popular Rightly or wrongly or both who knows which reasons are being used to justify it for people to use intravenous pushes of NAD and various settings it's extremely popular in Austin.
So I'd like to talk about that But first there's one that I have here in my notes That I'd love to know if you have any opinion on and I haven't seen this name in ages I do have some familiarity with it, which is depronil So I haven't seen this since I was an undergrad at Princeton freshman here reading volume one Series well later became a series called smart drugs Yeah, and it talked about off-label use of all sorts of things hydrogen Being another example perastem an arrest him long list of stuff But depronil was in that list and it talked about not just cognitive benefits, but also effects on libido and so on Do you have any opinion or thoughts on depronil? That's a really interesting one and in the context of aging It's sort of a mystery to me why this hasn't been studied more. So there are a few old studies of Depronil on lifespan in rodents and actually I think one or two studies in dogs That show pretty big effects and then it's like the literature just stops and I don't know why So this is one that based on that literature I think it's worth looking at I guess I didn't mention it because I had sort of slipped my mind But yeah there's as you might imagine there are very few things that have been reported to extend lifespan in dogs and This is one of two that I know of caloric restriction being the other one and that was in laboratory dogs So yeah, it's fascinating and like I said, I don't know why That was never carried forward or if anybody's still thinking about this too hard to slap a molecular modification on and patent I mean, who knows? Well, yeah, I mean that's a whole right That's a whole nother challenge for sure rapamycin is kind of in that boat too because it's off patent Yeah, maybe it had to do with a lack of profit motive But I I really don't know actually unless except for the people who were studying it were never in the mainstream Aging biology community and I think like, you know many other fields when work gets done outside of that To the extent that aging biology is mainstream never used to be but outside of that mainstream It kind of people don't know about it right or they just ignore it. All right, I'm gonna put a bookmark to revisit Depron L after this conversation and if people have some idea of why the Research stalled in the way that it appears to have stalled. Let us know on Twitter. I would be very very interested NAD precursors now NAD NAD plus Is there any difference between those two are those identical most people just yeah If you don't put the plus on there, everybody will know what you're talking about It's just so so there's any D plus and any DH and that's just the oxidized and reduced forms of NAD I see and this is a nicotinamide adenine dinucleotide is what that stands for and this is a cofactor in a whole bunch of different metabolic reactions Probably thousands and so it has a really important role in central metabolism but also a
lot of other cellular functions and you know, what has sort of emerged is I Don't know if I would say a consensus certainly a lot of papers published that NAD levels decline with age And the idea that if you can boost NAD levels that that would have a beneficial effect on metabolism now I am Massively oversimplifying and there are some very specific models which gained a lot of attention Related to how that's working But I think from a general perspective it probably is the case certainly in some tissues NAD levels decline with age the reasons for that are not completely known and there's some reason to believe that if you can successfully reverse that that there are some metabolic benefits to doing so and that's the general idea behind Intravenous NAD or NAD precursors, which are Small molecules that you don't have to take intravenously. So NAD is not taken up. There's no bioavailability if you just eat it So these NAD precursors are small molecules that in theory again There's some controversy around this but in theory have bioavailability and can be taken up to boost NAD in cells Yeah, I'm not gonna name names. I was talking to someone who's very skeptical of some of the dietary supplement companies that have been built around NAD Precursors including open questions around whether or not They remain viable if they are not refrigerated. So if they're on a shelf for two or three weeks Lots of open questions. What do you do?
Most Important Levers for Lifespan? (01:06:15)
aside from intermittent use of rapamycin for yourself in terms of Improving healthspan Potentially improving lifespan. What are what are other levers that you're pulling? Well, I can't tell you And close No, I mean the honest answer is rapamycin is about as edgy as I get and that's actually pretty edgy for a lot of people But um, you know the other stuff that I do is what what I try to do is I think what we all more or less Know we should try to do. I really don't take any supplements. I am pretty averse to supplements So that that might be something that's worth touching on again. You kind of alluded to this a minute ago But I don't take any supplements. I do periodically take vitamin D when I remember to that's mostly because my wife tells me I should but really what I try to do is I I found for me personally and I'm very much of the belief that Nutrition and diet is very individual for example my wife and I are completely different in the way we respond to carbs and I found that what works really well for me is a Low simple carbohydrate diet. I've tried keto just to try it, but I don't do a ketogenic diet But I do stay away Typically from bread and rice and you know, certainly things that have a lot of sugar added to them and that works really well for me But I'll also say I don't get cravings for that stuff. So it's easy. It's been easy for me to adopt that lifestyle I think that's been really important for me and it's been several years now that I've been doing that and that's helped a lot and If I had to pick one thing though, it would be resistance exercise. That is the one Thing that I think almost everybody should do to give themselves the best opportunity to be healthy as long As possible other forms of exercise. I'm not against cardio all that stuff, but I think if I had to pick one Maintaining your muscle mass and getting as much muscle as you can especially in your 40s and 50s is really important later on So I try to exercise and I and I enjoy exercising so it isn't a huge burden for me And then sleep is the big one right and I and that that's harder to control if you have trouble sleeping You can develop strategies to help with that But it's not like diet and exercise where you really have complete control if you really want to over that But that's a big one and I'm again have been really fortunate that I tend not to have problems Falling asleep and usually staying asleep. So oh what I would trade I Know and again, my wife is in the camp where she struggled with that a little bit And there are lots of strategies that people can can develop she found anything to help I don't want to speak for her. But I mean I would say I think partly Exercise so being physically active she gets out and hikes a lot and that helps not Napping during the day is is also a big one. I would say let's come back to our list of acronyms and I Also would like to speak about Chloric restriction of it. Okay, so I'll just pose a simple question.
Intermittent Fasting? (01:09:10)
Just should Molly be doing intermittent fasting as a stratagem for increasing Lifespan so I'm not a veterinarian. I do not give veterinary advice, right? We should say and I'll add another disclaimer to the top of this show I do not play on the internet. We are not giving medical advice. I'm not that kind of doctor Yeah, this is for informational purposes only so consult your health professional for any decision. I mean, I do think that's important So I'll answer I'll answer your question in a second But I mean I do always try to make this point because I as you might imagine I get asked all the time about Rapamycin for themselves for their dogs other things they should be taking and almost all of this right with the exception of diet and exercise And and the other thing not smoking things like that almost all of this is unknown territory, right and so I For myself do not feel that I should be telling other people what they should do I'm happy to share what I do and what I think works for me, but I None of this stuff has gone through clinical trials We have nothing that has been formally shown to impact the biological aging process in a positive way Increased lifespan and health span beyond like I said diet and exercise you mean in humans in humans. Yeah. Sorry Yeah, or even in dogs, right? That's we're doing the first clinical trial for healthy aging in dogs So I think people just have to recognize we don't have that level of proof and it's gonna be a long time And I shouldn't even say proof because there are things that go through clinical trials and then we find out later on that they aren't having the benefits people thought so I think we always have to recognize there's a level of uncertainty and Risk reward evaluation that has to come into that. Okay, I'll get down off my soapbox So should you consider time restricted feeding for your dog? So the first thing I would say is and this really I think you know the reason why why I even thought about this was because in The mouse studies and and this has been sort of popularized in to the the mainstream culture and people as well There are all these say calorie restriction alternative diets that people have started thinking about like intermittent fasting time restricted feeding ketogenic diet fasting mimicking diet and so That gets presented to the general public as if these things have all been proven to work and that's I'm just gonna say it That's bullshit when you actually look at the mouse data There is very little evidence if you don't calorically restrict that these things have any significant impact on lifespan Maybe some healthspan metrics, but they get presented as if they do. So if you do those things and calorically restrict Yes, they will increase lifespan in life. But if you limit your window and eat twice the number of calories Very very in fact if any or just isochloric. Yeah, that's right. That's right There's very little evidence that they have significant benefits. Okay, and in some cases it might actually make things worse So I but I've been so I recognize that and we actually wrote a review Going on a year ago now on this topic And so I thought our dogs in the dog study the longitudinal study of the dog aging project might be a really interesting Natural model to look at this because some owners feed their dogs once a day some twice a day some three times a day some Do what we call ad libitum or free feeding right? The dog always has access to food So as Google engineers when they have a snack well bar right around the corner This is actually a really fascinating question that I'm interested in which is certainly there's a self-selection to free feeding and dogs Right, if you have one of those dogs that will just eat until it gets sick. You're not gonna free feed your dog There's some probably genetic Component that some dogs can be have access to food all the time and they just won't overeat That's really fascinating biology there and I don't really think people understand it yet, but that's a different question so but but this occurred to me that we had an opportunity to actually look at this in our study and So what we did was we just looked at the survey data from the 40 at that time I guess there about 25,000 dogs in what we call the pack That's the the largest part of the longitudinal study and we just asked a very very Conceptually simple question if we've been the dogs by fed once a day versus fed more than once a day Are there differences in disease diagnoses now? This is all owner reported But in our primary survey instrument the owners are asked to list all the diseases that their dog has been diagnosed with So it's pretty good Maybe not quite as good as a veterinary record, but pretty good and we looked at I think 10 different age-related categories and I didn't think this was gonna work.
Daily Practices And Clinical Trials Related To Aging
Benefits of once-per-day feeding? (01:12:58)
Like I thought because I don't I still don't believe in time-restricted feeding despite the data No, that's not true I thought there was no way we were gonna see anything here But it was striking in six of the ten the dogs that were fed once a day Had lower risk than the dogs that were fed More than once it just just so I understand when you say six out of ten Yeah, so think things like cognitive function kidney disease disease Yeah, they were all going the right direction in six of them. It was statistically significant Which in my experience is a really really strong result were the other four No discernible effect or did they move in the opposite direction? No, they were all going the right direction They didn't just didn't all reach statistically significant. So then the question is is this causal? I don't know So again, these are this is an observational study. It's also what's called cross-sectional. So we only have one time point for each dog Correlation does not equal causation and you could think of plausible explanations here, right? So a dog fed once a day I'm guessing is less likely to be obese Maybe that's why the dogs fed once a day are at lower risk for a bunch of diagnoses, right? That seems pretty reasonable to me. So I don't know that the time-restricted feeding is causal for This outcome the other question is of course owners are thinking should should I change I want my dog to be healthier should I feed my dog once a day my Gut feeling here is that if your dog has been on say a twice a day feeding diet for? Several years I wouldn't change like we didn't change the diet for our dog I would not try to take a dog that's used to eating two or three times a day and be like Sorry, you're getting one meal a day from here on out I think what needs to happen now is an actual directed study to try to understand the first question Which is is it the case the dogs fed once a day directly to be experimental? Yeah, right So instead of being just observational do some sort of mechanistic maybe clinical trial kind of study We can through observation in principle answer the question our dogs fed once a day less likely to be obese Because we could just go back to the owners and ask that but then we really need to do studies to understand it Is there real mechanism here connecting once a day feeding to health outcomes? And even if it's just in about obesity once a day feeding might be a pretty good strategy to combat obesity at least in dogs Humans the problem with humans, of course, you know in where do we begin?
Seeking longevity while ignoring quality of life in the process (01:15:50)
Well, yeah Humans are funny animals. That's for sure with dogs. You can control when they're fed as an owner right now That depends a little bit on your ability to control yourself from giving you're saying I need a bigger cage for my kids But but in humans that's hard and here's the other issue I have with the whole dietary restriction nutritional aging nutritional longevity stuff is people pay no attention to the psychological consequences that go along with Trying to practice caloric restriction or trying to practice time restricted feeding or intermittent fasting I'm not saying they're bad for everybody But I know a lot of people who've dabbled with these things and and I would say some of the psychological effects aren't great but I think that comes down to the whole way that diet is integrated with our culture and our social interactions and It's hard to be hungry when you've got high calorie delicious tasting food and on every corner, right? So I think it really it does have an effect that we don't understand and don't pay much attention to Let's zoom out a little bit and just survey the landscape of scientific Research as it relates to I'll just use the term longevity for simplicity What are the constraints right now if any holding this field back? Is it as simple as funding? You know if Elon Musk decided, you know what? This seems like a good place to park some capital and put it to work I'm gonna dedicate 10 billion a billion a year over the next 10 years Yeah, does that on some level solve the problem or are there other constraints preventing? Research from being done. That would be let's just say Maximally valuable in the next five to ten years great question and we might get the answer to that So, I don't know if you've heard of this evolution foundation and I have not had evolution It's like evolution with an H. This is a foundation that is funded by the Saudi government and Some people have a lot of concerns about that. I personally have some concerns about that, but that aside Why is it called evolution health evolution? I think so. Yeah, okay And a lot of the female scientists I know really don't like oh he yeah Yeah, just saying I can see if you might if you can change that name you might think about another problem that China doesn't have Haha, it's all the same anyway So so in any case they have said and announced that they will be putting About a billion dollars a year into this area going forward I'm embarrassed.
Revolutionary funding scaling evolutionary medicine (01:18:14)
This is a royal degree This is there's like I don't know for sure This is what I've heard there have been two royal decrees in the last century and this is one of them So so we might find out so we'll see so first of all I would say it's gonna take some time if we just put the relative level of funding and we compare it to something like Cancer research so cancer research right now gets just from NIH about six billion dollars a year and that's not DoD and other sources of funding biology of aging gets about three hundred and fifty million So it's been minuscule compared to just cancer Where are all the billionaires who are terrified of dying and because I know they're dying when I meet these tech magnates. Well, I Very they're very eager to live to 120, but they don't seem to be I mean I think first of all, we want to be realistic and what we promise people right but or at least I do What you promise is just what they want yeah, yeah, I mean certainly there have been lots of stories written about high net worth individuals funding research in this area but what I would say is it's only been really I would say within the last two decades that the Research in the field has matured to the point where it legitimately Should be getting the level of funding that cancers been getting for the last 50 years right since the war on cancer was declared And I you know I got myself in a little bit of a little bit of heat on Twitter for saying this but I'll say it again because I believe It right it's funny because you get people working in the cancer field poking fun at the longevity field or aging research field Whatever you want to call it and I'm like look when the war on cancer was declared 50 years ago Cancer was the second leading cause of death in the United States behind heart disease. Guess where it is today number two So I would not throw rocks and when you've been getting six billion dollars a year at least for the last 50 years and I would also say and I think we'll find out if that level of resources was put towards targeting the biology of aging the payoff is Much much greater. I mean we can look at this in a lot of different ways But but one easy way to look at it because the math is pretty easy is what is the impact on life expectancy? from curing cancer For a typical 50 year old woman. Have you seen this before? What's your guess if I had a pill and I said this pill will cure all forms of cancer What's your guess for life expectancy? Okay, so this is we have we have a a healthy 50 year old don't don't overthink it population level Okay When which what what were expected what's the average increase in life expectancy if we just got rid of cancer took it out of the equation? For all human beings five years. It's pretty close three years. Mmm Yeah, same thing for heart disease if you do both you get about seven years So why is that it's because you didn't do anything about kidney disease and Alzheimer's disease and you know all the other Declines and function of diseases that go along with aging So if you take a different approach and you try to target the root biology that is leading to At least a permissive state for all of these diseases the potential to increase lifespan is much greater But really the potential to maximize healthspan is is even bigger, right? Because if you only fix one disease, you're not fixing all the other declines Whereas potentially you could fix many maybe all of these things at the same time So we'll find out but I think the promise is much much greater than it's ever been from this disease first approach.
Is it all about disease or can gerontology help in other areas of decline? (01:21:49)
Okay, so Again asking as a as an amateur in the kind of literal etymological sense of the word. I love this stuff and I'm involved on some level as a funder with early-stage science what I have seen is not all let's call it sectors or area of research are in a position to Make use of large amounts of capital. Yeah, so and it's a bit of a chicken and the egg problem perhaps But are there other things that would need to happen for let's say someone's listening and they say great This is what I've been looking for. I want to put a Hundred million dollars to work because I have so much money that I make that up every two years Anyway, or every year. Is there a way for them to even do that meaningfully at this point, right? I think it's a really important question. And again, I think we'll find out so I think the field as a whole if this billion dollars a year actually materializes one question is will it be deployed in a Efficient and useful way that we'll see but related to that is can it be deployed? In an efficient and useful way in other words are there projects where you could spend that much money? I think it will be hard but it's doable if Researchers from outside the field are brought in because right now it's a fairly small pool of people who've been trained in the field and I know that's part of the goal with evolution is to Entice other people to come into the field the place where if it was me The more I think about it the more like wow, it isn't a very fascinating branding decision like They could have had a second meeting on that one. But yes, please continue and now the billion just also so I have a clear understanding Is that billion in part allocated to for-profit ventures? Yeah. Yeah, it's interesting So this is my understanding and they may change it but my understanding is roughly two-thirds will go to nonprofit as grants They call them donations for some reason but same things what we know of as grants and about one-third will go into investment So that that's the way I understand it. Yeah, right Yeah, I think that's good I mean, I think it's good that they're they're thinking about both the the private sector and public sector for sure is the What was the term you used for the area aging research? Is that the way to put it? I suppose I call it all sorts of stuff. But yeah, so if I think about my experience in Science related to psychedelic compounds broadly speaking when we start to get into therapeutics as I understand it the FDA is very interested in the ability to scale and deploy a given therapy for Significant number of patients in the population. So in other words if the infrastructure or other Doesn't exist for instance the number of therapists required to administer compounds that Entail a session that is four to twelve hours in length there are a number of issues that need to be addressed before the FDA will say reschedule something or Allow it to be prescribable Has any of that cropped up with the aging research and compounds that are being? Examined or because they are already in circulation like rapamycin That just doesn't really exist as a problem. So I haven't heard that specific problem Let me come back to FDA because I think this is a really this is there's a lot of people in the field that have been Thinking about this and there's a lot of confusion around how you would actually get in what we would call a gero science intervention I haven't introduced that term yet, but gero science is the area of research that ties together The biology of aging with age-related diseases and when you're thinking about moving a drug into the clinic You have to have an endpoint a disease or an indication That's what FDA approves a drug based on and gero science is really the connector there So there are lots of people thinking about that. I want to come back because you asked me What would I do if somebody gave me a billion dollars? Yes, and I want to answer that question There are people there are people who actually do have the capacity I do think there are a couple of big areas You don't give me a billion dollars, but where I would like you could if you wanted to We'll put the wire wire wire instructions up with Trust me Anyways, I think there are a couple areas where the field could benefit from a large infusion of money one has actually in marketing and what?
The psychology of aging & geroscience IVCs (investigational clinical trials)! (01:25:57)
I mean by that is I think that we as a field have never been very good at communicating with the general public and with policymakers around why this area is important and we've been we broadly speaking have been very bad at Talking about the nonsense right the hype and the snake oil and all that stuff. So I think a dedicated marketing plan with professionals for how do we communicate The importance of this research in this biology to the general public and to policymakers And that's not going to cost hundreds of millions of dollars But I think if you put a significant amount of money towards that you could have an outsized impact The other area where I would put it are clinical trials Clinical trials are expensive big companies are scared of moving into the Geroscience biology of aging space because they have yet to see a path to FDA approval for a drug to target aging So if there was a lot of money available to accelerate that and create that path Then you know big pharmaceutical companies are followers, right? They're gonna follow what has worked for somebody else then they'll come into the field I think creating that path is important and that's really One of the reasons also why I pushed so hard for the rapamycin clinical trial in dogs I thought rapamycin was our best bet but there's no guarantees clinical trials can fail even if your intervention is great But I wanted to create a template that others could follow and I think we've been successful at that There are now a couple of companies that are actually moving forward with developing drugs and starting to think about doing clinical trials for aging In companion animals, so I think that same kind of template on the human side would be really valuable And so really I'd love to see three or four or five big clinical trials in people Targeting indications relevant for the biology of aging and I think that you could spend a billion dollars doing that Do you have any suggestions for what those might look like? within a Timeframe. Yeah, that would be I'm struggling for the adjective here practical, right? Because if you don't know someone's dead Yeah, there there are issues with Awaiting and not just awaiting those results but funding something for absolutely So, I mean that's the beauty of course of doing a clinical trial in dogs, right? We all know dogs age about seven times faster than people do so you can do a lifespan Clinical trial in a reasonable time frame if you start with middle-aged dogs, and that's exactly what we're doing You can't do a lifespan clinical trial in people because it's instead of three years. It's gonna take you 21 years or whatever, you know roughly so so what would you look at?
Clinical trials of aging considered disease by disease, not as a syndrome or cluster. (01:29:00)
So there are a few strategies that people are taking one is the kind of strategy that is being taken with the targeting aging with Metformin trial or tame trial that I mentioned that's what's called a morbidity study, so it's looking at frequency of age-related disease diagnoses and specifically The length of time that it takes from when somebody is diagnosed with one age-related disease before they get the second age-related disease now the conceptual advance with tame and I think why it's potentially powerful is they have gotten agreement from FDA to consider a collection of age-related diseases as one Indication one endpoint sort of like a syndrome X type of situation So what that then gives you is sure any one person may have a low percentage chance of developing Alzheimer's disease or age-related cancer or kidney disease, but if you get Diagnosis for any of those as your endpoint then you have a much higher chance and it takes less time to do the study So that's one approach, right? It's still a disease focused approach But it's a collection of diseases as opposed to a single outcome the other approach and I think that this could absolutely be done is to look at Age-related indications that have a shorter time frame so functional measures of aging so you can look at a variety of functional measures of aging one Example would be immune function, right? So there actually was a company that tried to do this. They were called restore bio They were actually working with a derivative of rapamycin at first and they published two Clinical trials where they showed that in older people of normal health status I'm intentionally using that kind of ugly phrase because I don't want to say healthy older people Because I think people don't understand they when they think healthy they think that it is like fully functional I'm a healthy 51 year old as we've talked about. I am also a damaged 51 year old. So I'm not I'm healthy I'm abnormal health status, but I'm not fully functional So anyways an aging survivor.
Scientific Literacy And Substance Studies
trial of mTOR that benefited influenza response but was terminated early (01:30:51)
That's right So so they did this study in in older people who were you know who are functioning? Appropriately for their age did not have any significant age-related disease To face to clinical trials showed that six weeks with the derivative of rapamycin boosted influenza vaccine response They went to their pivotal they switched the drug took out the rapamycin derivative put in a different mTOR inhibitor that works by a different Mechanism and they weren't hitting their end point. This is a little bit of a tangent, but it's a fascinating story They weren't hitting their end point Which was patient reported infections So the FDA told them that they had to go with patient reported instead of laboratory confirmed, which is crazy in any case makes no sense, but FDA FDA felt that patient quality of life was more important than whether they were actually Joan Manick has a paper anyways, so they weren't hitting the end point They were gonna do two trials one in the southern hemisphere in the flu season and the other in the northern hemisphere I think they got to the southern hemisphere and They got the interim results for the first half of the trial and they weren't hitting the patient reported endpoints And so the board of directors voted to stop the pivotal clinical trial instead of spending the money on the second half November 2019 was when that decision was And I can't help but think if they knew where the world was going to be five months later They might have thought differently so it turns out Joan has published now in an after report That not every virus but for several viruses the people who got the mTOR inhibitor had much lower rates of Significant infections over the next year. How long did the the administration last six weeks Wow Yeah, six weeks and then I think it was a six month follow-up Interestingly there were three viruses. I can't remember what the third one was. There were three that had strong effects one was influenza The other was coronavirus wasn't kovat 19 because we didn't know about kovat 19 when this was study was happening But I mean imagine if we'd had a drug that you could take for six weeks and it would reduce the likelihood of severe Outcomes and death by 50% It's amazing that is so lucky timing Yeah I remember being at the it was the GSA meeting in November when that was announced in Jones GSA a Gerontological Society of America. Yeah again, I know it was a tangent I don't actually remember what how I got going on it, but I think it's an important lesson for How valuable this kind of an approach could be right if you really could modulate the biology of aging it will Improve age-related immune function. Yeah, we started with what you would do or how you think about it If you received a billion dollars trial So I think that's an example of a functional measure of aging that can be done in a reasonable time frame in a reasonable population site the other one that I would really Do is or think about doing a series of clinical trials on or and certainly with rapamycin a larger trial than what John's doing Is periodontal disease because the endpoints are just so great These are endpoints that any dentist can do in an exam and if we have an effect there, I think it's a really Straightforward path to FDA approval if you can actually show that you're having an effect on periodontal disease It's interesting because you know when we were when we were first Going down this path, you know, we thought about spinning out a company to look at periodontal disease and aging I still think I'm gonna do it someday But we talked to VC and you want to know the reason why they didn't want to do this They're all VCs are always looking to get to know and these guys drive me nuts. I Do want to know why they said no because they were afraid that you couldn't get the insurance companies to pay for the mouth Which is true, right insurance billing is done differently than the rest of the body and I get why that's a concern like I understand Okay, that's a concern. I can't believe if you had an intervention that reversed periodontal disease You would not be able to figure out how to make money on that people would pay out of pocket There are I would say a lot of people Me that that's why they torpedoed this whole thing is but anyways, that's another tangent So I but I do think periodontal disease is a great clinical trial endpoint Because we expect the effects to be seen relatively quickly and it's and it's not invasive, right? It's not hard for patients to participate Yeah, I'm just imagining if that were approved, you know overnight you'd have 200 million or 100 million people Diagnosed with period Be kind of like at one point. I don't you remember this I track this stuff pretty closely But at one point almost all of the top sprinters in the world were diagnosed with narcolepsy Because they want to use modafinil why yeah because it's a performance enhancer But that's a side note Let's talk a little bit about Hype and snake oil. Yeah, which are strong ways to put it but hype is a reasonable way to put it and closely related to this is how people fall for hype and snake oil and I think that undergirding some of that probably fancy way to put it is just a lack of familiarity with study design with understanding Absolute versus relative risk and things like that, but I've retweeted a tweet of yours a while back that may Be worth mentioning which related to short-lived controls.
Why people (including scientists) fall for snake oil and hype (01:35:50)
Yeah, could you just describe this? Sure I think it's it at least for me was like in retrospect so obvious when you pointed it out It's kind of like the doorknob and in the sixth sense, but you don't notice it through the whole movie I'm like god there was the whole time. So could you just explain this and we'll we'll build off of that I think the first thing to say is this short-lived control so falling for the hype can happen In different groups and so the general public can fall for hype as it gets presented in this field in other places But scientists are susceptible to this too And I think this is an example of how scientists can fall for I don't even know that I would say it's hype but be Misled by the way data is presented to believe something that isn't as strong as it seems So this specific case refers to the fact that you know when we do an experiment in mice Let's just start with mice for lifespan The untreated group so in a typical lifespan experiment You'll have a control group and then you'll have say your rapamycin treated or whatever metformin whatever it is You're testing the untreated group. We kind of know Within you know some variation how long those animals should live because lots and lots of people have done experiments those kinds of experiments and it depends a bit on the the quality of care that they get so animals that are in a facility that has Pathogens or is dirty or they aren't getting good care are gonna live shorter than animals that are well cared for that kind of makes sense So just to put some numbers on it. Let's say the normal lifespan for Black6 which is the most common mouse strain used in biomedical research is you know somewhere around 900 days You will see lots and lots of experiments in the literature where the controls live 650 days and then the drug Or whatever that was claimed to extend lifespan extended lifespan to 700 days So often what happens is those experiments where a lifespan extension is claimed Starting from short-lived controls don't end up being reproducible and I think I can't prove this but I think it's because there was something about those controls that made them sick and Whatever the intervention did it was in that context and it doesn't work when you try and do it in Controls that lived as long as they're supposed to the other thing that's important to recognize and this is why I try not to do This it's hard not to because we've done it even in this talk But try to recognize that when you present the lifespan extension as a percent That's a numerator and a denominator And so it's the difference between the treatment and control group divided by the control group if that control group number is small That makes the Percent effect big so if you have short-lived control something that would be maybe a five percent effect if the controls lived as long As they were supposed to becomes a 25 percent effect. So there's two things going on there that I think tend to inflate the belief in a result when these experiments happen with short-lived controls and of course Two things additional to say on that you got to actually read the paper to even notice this and I have found that Many people who should be reading the papers are not actually reading the papers They're reading the abstracts which don't show this They just show the percent and you have to recognize that these in fact were short-lived controls compared to what we would expect Based on the literature. I'll give a quick plug for Peter again, he has a series of blog posts.
Separating signal from noise in scientific literature (01:39:41)
He's also done a number of Q&A's or ama's related to this but Studying the studies. Yeah is worth Perusing it's worth it's worth taking a once through as a reader if you want to develop a greater ability to separate signal from noise True, I shouldn't say true real from not real and just sloppy from cleaner Science and certainly science communication. It's worth taking a look at can I just stop you there? So I think that's really important But it's also really hard for people who haven't been trained in the field to do that I'm certainly Recommend that people try to look at the primary literature and you know at least to the extent that you can figure out What's happening? It's really hard though I remember when I first started trying to read papers in scientific journals every other every other word It's like a different language. The reason why I bring that up is because then what do you do? If you don't have that technical background, well you rely on Communicators to give you that information, right? And I think that's where this field in particular has really done a terrible job because most of what I see getting communicated to the general public and usually it's to a fairly educated portion of the general public is full of misinformation and exaggeration and sometimes outright Pulsifications that's where I really think we need to do better I don't know if that's unique to this field because I know it happens in other fields as well But I think this field is particularly bad at that and you know, I would really like to see the influencers for lack of a better word not you because He's winking at me right now. You are an influencer But you don't typically, you know post about the latest and greatest longevity intervention super food sign up for my free book. I would really like to see especially those who have scientific credentials do a better job of Communicating the excitement around what's happening and the reality of what's happening without all of the exaggeration And I'm gonna use that word because it's nicer than the other word that I'm thinking of There's a lot that I want to build off of in what you just said so Related to the short-lived controls and I will please call me out if I say anything stupidly here Which I am prone to doing when I weighed into these areas has anybody ever actually done that to you like that was stupid Well, they'll correct me. They'll correct me. They may not berate me and hit me or the rolled up newspaper, but they will say well That's one way to put it.
Metformin and its effects on resistance training (01:41:54)
Here's another way to think about it because you said it like a complete idea My filters on them. All right, it's important also to look at the condition in some cases comorbidities in the group that is being treated right when you're looking at percentage or absolute yeah changes and what brings This to mind for me is actually metformin and I'm not familiar with the literature to the extent that you would be but I remember speaking with someone I would certainly consider an expert with respect to metformin and we'd out of spend some time together and His perspective was for say me that it would not make sense for me to take metformin because if I'm watching my diet and I am doing resistance training and so on that the Expected value of that Delta would not be worth Ingesting another pharmaceutical which is part of the reason that I maybe unfairly took it off of the the list of candidates And I was asking you for second and in third place Coming back to the sort of hype hyperbole, etc And I'm not automatically putting this in that category, but it seemed like you had a lot of good things to say about NAD precursors So why not do infusions? Why not try to replenish NAD? Let's touch on metformin first and then we can come back to it because NAD we could spend two hours on that alone Okay, I don't want to go So metformin is really interesting, right? So the reason why I wouldn't probably put it at the top of the list I know I wouldn't put at the top of list in dogs is in mice metformin doesn't actually Reproducibly extend lifespan. It depends on the strain background It does seem to work in a very short-lived cancer prone strain, but outside of that not really so it's not in the same Category of things like rapamycin or a carbos or things that robustly and reproducibly extend lifespan and in people This is where the data is kind of interesting because definitely if you're diabetic or metabolically compromised you get a mortality benefit from metformin there is a hint at least in certain populations that diabetics taking metformin may Have a mortality benefit compared to non diabetics not taking metformin That's kind of the best argument from mortality perspective in terms of testing metformin in people my intuition aligns very well with what you described in that I don't personally think there's a high likelihood that metformin is going to be beneficial for people who are Not metabolically compromised and you know eat a relatively good diet and are active. We have a friend joining us So that's my that that's my feeling the other thing is there is there have been a couple of reports Well another one just recently, you know suggestive I would not say it's rock-solid but suggestive that Metformin may actually counteract some of the benefits of resistance training. So that's another reason why I wouldn't For myself really consider taking metformin All right. Okay metformin check NAD or NAD precursors. NAD is super complicated so the first thing is NAD itself in order to take NAD you either have to do it as an infusion or Apparently I've heard you can inject it into your butt.
What to know about NAD and NAD precursors (01:45:23)
I've never done that booth moving in ad so I Boofing in ad.com folks. So 10% discount discount code Promo code Tim I got a half percent profit share, but don't don't read the fine So that's not for me. But also I think it's you know, there is a question even whether or not intravenous NAD or NAD injections give you a real boost in bioavailable NAD in cells and tissues The same thing can be said about the NAD precursors So, you know you alluded to this that it's not clear how stable they are and and you know There've been questions around the companies that are selling them even the people in the field who are supposed to be the experts on these molecules and there are two that are commonly talked about and studied nicotinamide riboside and nicotinamide mononucleotide Even the people are supposed to be experts in those molecules and then would be in a minute. Sorry Yeah, oh no, I'm just in our because people might write in our versus in a man Even the experts can't agree with each other about them and you know One side will say the other one's not bioavailable the other side will say the other one, you know It's it's like come on guys. This is a solvable problem scientifically So that gives me some some skepticism The other thing is when we tried some experiments in my lab with both NR and NMN and we never got it to work I know other people do but it does make me think that there are Experimental details that are important like do you have to keep it in the refrigerator? Can it be in the mouse food for 24 hours before you give it to them right? Are there some things that we don't understand? About why it works sometimes and why it doesn't work other times that need to be figured out And then I think there are still questions about are they useful and that's a different question, right? And again, the data is mixed So, you know There was one paper that had a short-lived control problem where nicotinamide riboside was claimed to extend lifespan The interventions testing program tried to reproduce that and they couldn't at any of the three sites So does NR extend lifespan in mice maybe but probably not nobody's done an NMN experiment yet that I know of for lifespan in mice So it's kind of striking how much attention these molecules have gotten When the actual body of evidence I wouldn't say it's weak. I mean there is smoke there There's a lot of smoke there, but it's not clear that there's much fire yet. And so I'm waiting to see how it plays out next up for Examination resveratrol.
What you should know about sirtuins (01:48:08)
Oh god And this might be a Helpful place also because people who have attempted to educate themselves. Let's just assume that they're not going into studies in the fields of aging longevity Extending health span or lifespan are probably going to come across the sirtuins. Yeah, so if maybe you want to tackle those two So I'll start with sirtuins. So sirtuins are a family of proteins that are named after Sirtu and that's a yeast protein. So this was first discovered in budding yeast. Sirtuins are What are called this is a little bit of a technical term. They're called NAD dependent Deacetylases there are a couple of other activities that they can do as well But the NAD dependent part is the important part here and this ties back into the NAD precursors and what this means is that their activity uses NAD and Unlike many of the reactions the metabolic reactions that NAD is used for sirtuins consume NAD So what most metabolic reactions do is they take NAD the oxidized form and convert it to NADH The reduced form and that can happen in the cycle, right? That's easy Sirtuins actually break down NAD. So you actually lose NAD when sirtuins are active and they require NAD and this gets back to the decline in NAD activity with age as NAD levels go down the prediction is that the activity of sirtuins go down and sirtuins do a whole bunch of stuff It's way beyond the scope of this conversation to try to talk about what people think they know about what sirtuins do but sirtuins got very Popular in the aging field and that really goes back to my graduate work So the first project I had in Lenny's lab was studying the yeast Sirtu at that point We didn't know what it did We didn't know what the activity was and we had a reason to think it might be involved in aging And so my first project was to overexpress Sirtu So I've just put a second copy of the gene into the cell and we found Mitch McVeigh and I did this He was a graduate student at the same time. We found that that was enough to extend lifespan That's how sirtuins got started in the aging field and I'm not sure whether I deserve credit or blame for this I'm pretty sure I deserve both You mean I should thank you for learning there if I drink more red wine, I'll live longer? There would be no conversations around sirtuins and aging I don't think if that experiment hadn't been done in any case What really got people interested though was when Heidi Tissenbaum who was a postdoc in the lab Showed that if you took the the worm version, this is C. elegans, which we touched on earlier Took the worm version of Sirtu which is called SIR 2.1 and overexpressed it in worms You could extend lifespan and then other people showed the same thing in flies and at that point, I think everybody got excited that this may be a new family of enzymes that affect aging and This might tie into a topic that you might want to talk about. They affect the epigenome The histone deacetylases are our epigenetic histone acetylation is an epigenetic mark Which is also interesting in the context of aging So that's why everybody got excited and then I don't know how many hundreds of millions of dollars have been spent Trying to prove that the mammalian sirtuins and there are seven of them SIRT 1 through 7 or sirtuin 1 through 7 are important regulators of aging and there's one case Maybe SIRT 6, maybe is important for lifespan. The others have just completely fallen flat So that's why I think there are some people who are very dismissive of sirtuins and I don't I'm not in that camp Sirtuins play really important role in biology and they actually some of them function in the same network as mTOR My view is they just don't seem to be very good nodes in that network for having the effects that we want on longevity But it is sort of striking how the entire field or a big chunk of the field was led down this path Of sirtuins being the center of the universe and there was never ever evidence to support that And I think most people have kind of moved on but they still get a lot of resources put towards them So that's sirtuins I also wonder just a quick side note and then we'll get to resveratrol how much of that mimetic spread and Momentum was because sirtuins are easy This is going to sound stupid but easy to say compared to a lot of the terms that we've used in this There's no right answer. It's just it's easy for a lay audience and for people to repeat. Yeah. Anyway, it's an interesting idea I don't yeah, I don't know. I mean the question of why some ideas, you know Catch on and take over is fascinating and that happens in science all the time I do absolutely remember meetings where it was like, you know, 50 sirtuin talk that has stopped but for a while That was the case. Okay, but I do want to say like I haven't I I have not given up on sirtuins as therapeutic targets for aging I just haven't seen anything yet that makes me convinced that that's a useful strategy, but they probably are therapeutic targets for something I mean they do play important roles in in biology. I don't want to make it sound like that So resveratrol, right?
Resveratrol Examination And Change Resistance
The resveratrol tale (01:53:24)
This is a complicated story. So resveratrol is of course the the molecule from red wine. That's how it kind of got popularized and famous Why are you smiling? I'm sorry I'm smiling because it was just hilarious to me how quickly the motivated reasoning in the media converted it into Your wine habit is justified. Not only is it justified you should drink more red wine. Yeah. Anyway, yeah So I'm gonna digress and you just tell me if I'm getting too far in the weeds But I think it's useful to go back to where this all started right? So so resveratrol has been around forever It is a natural product polyphenol found in the skin of grapes. That's why it ends up in wine. It's also found in other plants But it's been studied for a long time in pharmaceutical science And in fact, I only learned this after you know, we were working on resveratrol, you know it turns out that resveratrol has come out of Probably thousands of screens at pharmaceutical companies for different activities It is probably one of the dirtiest drugs that are out there and I don't mean that in a disparaging way This is a technical term. Okay, so So a clean drug means it has one biochemical target and one only. This is a promiscuous Rapamycin is an extremely clean drug from that perspective a dirty drug Finds to a whole bunch of stuff and has all sorts of effects, right? So it's hard to predict and it turns out resveratrol is extremely dirty And it's come out of lots and lots of pharmaceutical company screens to the point where they just ignore it Right if it comes out, so this has been studied extensively how this got into the aging community was a study done by David Sinclair's lab I think it was published in 2003 where they reported that resveratrol was an activator of sirtuins and specifically yeast sirtu And mammalian sirti one so two specific sirtuins. I think they looked at in that paper And they reported that Resveratrol could increase lifespan in yeast. I mean it was published in nature Which is a one of the one of the high profile journals, but that didn't get the attention of the media the subsequent study Where they showed that mice on a high fat diet Lived longer if they were given resveratrol Was the one that started sort of the media firestorm and so David started a company called Surtress again playing on the sirtuin brand and they were very successful at marketing the story that Resveratrol was an activator of sirtuins. We would test other drugs like resveratrol to activate sirtuins and we would have effects on Longevity and healthspan that was the story there and then the fact that resveratrol is in red wine. I mean gasoline on the fire If I was going to pick a drug that I wanted to sell as my longevity drug It's hard to pick one better than the one that is found in red wine There's that's a great story.
Story about early resveratrol experimentation (01:56:08)
So anyways So how do we get from that to where we are today? Which is pretty much nobody's paying attention to resveratrol in the field. In fact, it's funny because I was at the American Aging Association annual meeting just last month And somebody asked me about resveratrol and I looked in the the abstract booklet and the term was there once So one person had a poster on resveratrol and the phrase was the resveratrol treated animals were no different than the controls So I think the field has moved on So how do we get from there to here? So my piece in this story, which is a small piece in the story, but at about the time Between when the yeast paper came out and the mouse paper came out Brian Kennedy and I were testing a hypothesis that caloric restriction was working through SIR2 So specifically in yeast that was sort of the model that had been proposed and we were testing that And we had some evidence that argued against that we could show that we could get rid of SIR2 and still Get lifespan extension from caloric restriction and we had read David's paper and we thought this would be a really good tool We're using resveratrol to test this a little bit more because we could use it as a drug to activate SIR2 And see what happens if we combine that with caloric restriction. So that was my only rationale for studying this IV injection. No, no, this is just cells on a plate. Got it. I see. I'm sorry. So this is really easy really simplistic and so we tried that and We could not get resveratrol to do anything to the yeast like they didn't live shorter. They didn't live longer We tried all sorts of doses. We tried, you know Keeping the plates in the dark, you know We tried everything we could think of. Talked to David, tried to get an explanation from him. We couldn't get it to work So then we started asking so why can't we reproduce this lifespan extension? And I will say the lifespan extension that was reported in that first paper was huge. I mean it was like 70 percent which is A big number with normal lift controls like it's hard to imagine It was hard for me to imagine That that was wrong because you can't be wrong by accident by that much. The statistical likelihood that you would be wrong by that much is Very low. So we started trying to figure out why couldn't we reproduce this and so we did a whole bunch of painstaking biochemical experiments where we finally figured out that Resveratrol was not activating SIR2 in the cells That's called in vivo, but it could activate SIR2 and SIRT1 towards a very short peptide and this turns out to be the peptide that they used in that first paper where they put a This is again a little technically complicated but they basically put a chemical group on the end of the peptide and it was that chemical group that changed the conformation so that SIR2 could be activated towards resveratrol. Now, no proteins in our body have that specific chemical group on them So that explained to us why resveratrol was not activating SIR2 and extending lifespan in yeast I still can't explain how they got the lifespan extension that they reported I'm not even gonna try but that explained to us why we couldn't see anything in yeast It also left open the formal possibility that maybe there are some proteins in the cell that Looked sort of structurally like this chemical moiety and that resveratrol could activate SIR2 and stores What was that word used? Moiety? Moiety. Yeah, a group. I don't know It's a word I learned, you know at some point in graduate school. It's a chemical structural group. It's a great word. Yeah, so You've got a number with me recently. I think we were pretty Appropriate in the title of the paper. So we said resveratrol is a substrate specific activator of sirtuins It just turns out the only substrate we could find was this artificial one that only works in a test tube But maybe it works in some cells sometimes. So there have been a lot of back and forth arguments back and forth I was like, I'm done I want nothing to do with resveratrol after this but other people argued about it But the one thing I will say so so and again, it's hard to close a door Once people believe that something is true It takes a long time to convince the field that that is not the case. I think we're there now So there was a meta analysis done relatively recently Looking at most I won't say all but most of the published studies where resveratrol has ever been tested and it's the largest database of Aging experiments that's out there and ask the question if we look across all the organisms and all the experiments What is the consensus and the consensus is no effect So every experiment that's in this database you look at the effect of resveratrol and it's zero and that's like dozens Maybe hundreds of experiments. So I think the story is told and yet I really didn't want to call David out on your podcast, but I'm gonna call this one thing out He still posts about resveratrol and I'm like look man. I would stop if I was you this is done Now the other thing I'll say Resveratrol does have biological activities.
Newer data, continued focus on resveratrol by Sinclair (02:00:59)
I mentioned it is a dirty drug and there are Epidemiological studies there aren't any of them that are particularly good as in my view But there are epidemiological studies that suggest that sure people who do mega dosing of resveratrol may have some benefits Probably not lifespan, but maybe for cardiovascular disease or something like that So I'm not saying resveratrol isn't going to do anything I'm saying it seems clear to me that it doesn't affect the biology of aging robustly and maybe not at all Let me add a layperson's Resveratrol story Very short, but I became somewhat interested in resveratrol in 2008 when I was initially working on the four-hour body long time ago back when I had hair and I became very interested primarily in the potential endurance or purported endurance Enhancing effects. Yeah, and I have Terrible terrible endurance.
The resveratrol story. (02:01:43)
I will I will leave it at that I have some funny stories in the four-hour body related to working with sports Scientists who did muscle biopsies and looked at my like citrate synthase and so on. It's quite funny It turns out that I am kind of below Homer Simpson in a number of them tragic funny that kind of like crying clown kind of funny, but the entire Process of reading into resveratrol led me to start using it and two things company bottles a day. I Was red wine. Oh, no cases right how many cases of red wine I ended up purchasing a supplement and Ended up consuming most of each bottle each day I mean just because of the dosing regimen involved there were two things that came of it number one And I can't remember the name of this I did put it somewhere on my blogger in the book but there was some type of filler used in the capsules that also had a secondary use as a Laxative so I very unfortunately ended up feeling like I was preparing for a colonoscopy was terrible Secondly once I figured that out and modified the supplier I was tracking loosely Conversations on something that was called It was either the 500 Club or the 500 forum something like that and it was a bulletin board for people who had been taking 500 milligrams per day. I want to say of trans risk very true. Yeah, and I after a few Weeks somewhere between week three and week eight Developed and this is anecdote Obviously plural of anecdote does not equal data or study, but I developed incredible joint pain in my elbows yeah, and It was the only new variable that I could pick out in my regimen and Went into the forums and found a lot of examples of people complaining Yeah, anyway Just as a side note also to underscore that you don't always get a biological free lunch with unlimited upside and no downside You never do right. I mean, I think that's something that's important to appreciate right there Always anything you do in a complex biological system and human beings are extremely complex is going to have Unanticipated consequences now it may be possible that you could get a longevity intervention that that has no Significant side effects, but I'm and I guess depends on what you mean by significant. Yeah, I'm skeptical resistance training. I'm skeptical. Yeah, right Well, there are a lot of side effects to resistance training. My legs are sore right now In terms of taxes to be paid it seems reasonable so but yeah, I mean I think you know again That's the challenge with these supplements and and I and like I mentioned this paper was published in 2003 So 20 years it's taken to clean this mess up and it's still not cleaned up and there are still a lot of people like I'm Sure, I will get some hate mail from saying what I said about resveratrol Although I think everything I said is accurate in terms of the data There are lots of people who passionately believe in resveratrol and you know, the data are what they are. It's not gonna apologize It seems like we could almost think of these interventions as a I'm gonna try to imitate Peter T The best of my ability and pull out my McKinsey hat which I never worked for me kids Even let's say we had a two by two matrix.
Leakymitochondria threshold?. (02:05:15)
They gave you a hat and you have sort of Doesn't work does no harm does work Does no harm then you have doesn't work does harm does work does harm does that make sense? Like you could you know, in other words you you could you could take something that has no downside in which case fine If it does no harm But there are often as you pointed out if not most of the time these trade-offs and or unintended Side effects and take intravenous and it is an example So I did she's a curiosity because a number of high level athletes were kind of badgering me about NAD and and claiming all these Benefits. So I was like, okay fine I'll do a series of say five infusions these IV sessions and For anyone who hasn't experienced this. I think I think it's a fair description if you imagine When you are getting not necessarily a push but an IV drip with NAD it feels to me like a combination of being hyper Caffeinated in the sense that you get that creepy crawly sort of fidgety tweaker feeling but without any of the upside and then you feel like you have Andre the giant sitting on your chest like there is a pressure and sort of smothering feeling and I observed this in everyone in the room. It wasn't just me I mean it is a highly it can be a highly highly highly uncomfortable Experience and the reason I bring this up is not to say people should never do it. It's just like okay, there are costs and That should be it seems part of the calculus Yeah And I would agree with that completely and I and and this is something I try to Communicate right is that we don't know all the costs and there could also be unanticipated benefits to lots of things but I think trying to take an open-minded view of The potential side effects actual side effects potential reward in all things is important I actually think this is really I mean this also ties into I think one of the challenges we face in the field of Trying to bring jarrow science or aging biology mainstream from a clinical perspective is most physicians are trained to do no harm and did not to treat people who aren't sick and I understand the rationale for that but in the context of aging We know exactly what the consequences well, maybe not exactly everybody experiences different problems But we know ultimately what the consequence is going to be of doing nothing So but that never gets taken into the equation right of what is the risk reward?
Overcoming resistance to change (02:07:04)
Considering that there's a risk of doing nothing There is an absolutely a huge risk of doing nothing to maintain our health as we get older But people don't think of it that way and physicians don't think of it that way And so we have to start to change that mindset to weigh that into the equation Sure rapamycin may have some low level of risk But there's the possibility that it is going to increase your healthy lifespan by 10% How much risk are you willing to tolerate? You ask the average person they in their head can do that maybe to some extent analysis, but a physician Immediately most physicians I shouldn't say this It's a generalization but many are very resistant to the idea of doing anything for somebody who's not sick To keep them well, and we have to change that Do you think it's a liability issue and therefore it could be fixed with? some degree of Change with respect to I don't know how you would catalyze it, but sort of defensive medicine, baby Yeah, so I think that could be part of it. I don't think most physicians and again. I guess I these are just Conversations I've had so I this is my impression, but I don't think most physicians at least think of it that way I think it really comes back more to the training that they receive the Concept that you do no harm, which I mean I understand that concept But they're never trained to think about what the harm of doing nothing might be and I think there is no component of a medical school curriculum yet that educates medical students on The fact that the biology of aging is modifiable and that's a relatively new concept for a long time Everybody thought you couldn't do anything about it I mean everybody recognizes that age is the greatest risk factor for cancer heart disease kidney disease, you know go down the list There's like 20 of them, but everybody thought you couldn't do anything about it Now you can or at least We're close. We know we can modify aging biology in laboratory animals. So Starting to get that training will I think change the mindset. I'm sure there is a liability component where Physicians are hesitant to do anything that will risk malpractice. I actually think that's probably a pretty tractable problem. I think as People become more educated in this area insurers will Recognize that from a cost perspective if you can keep people from getting sick that probably is economically more viable than paying Tens of thousands of dollars for the last three days or eight weeks or whatever of life, right? Let me if I may zoom out a little bit look at your I want to take a closer look at Science overall as consent strange to put it that way but also something that that strikes me as we're talking which is and I have a notes in front of me of course, but You do not seem tell me if I'm off here.
Scientific Bias, Recommendations, And Closing Remarks
Implications of the publication bias in science. (02:10:47)
You do not seem to have an aversion to Conducting studies that fail to replicate or turn out with its right terminology like a null effect and I want you to correct my terminology, but there is a positive publication bias in science, yeah, and I look for you to just maybe speak to how you think about science and The purpose of science what it can and cannot do maybe the way people get confused by it Because it's the type of work that you're describing and that you've done is so so important and if people are afraid of Rejection whether that's by peers or by journals So they go after kind of the shiny new object hoping to show a huge amplitude of effect with a new intervention That has all sorts of negative Implications. So anyway, that's a lot of talking. I'll start to try to address that I think there are many there's a lot to potentially unpack there but I think one way to think about this and you know this is something that I have thought a lot about throughout my career and especially as I've become more senior and I'm training people and my view is especially in biology, but I think this is true in almost every scientific discipline that our goal should be to Develop the best model that we can for whatever it is that we're studying right that could be a biochemical pathway Or it could be a model of aging right or usually it's gonna be somewhere in between the best model that we can to explain The data that we've got at that time and then what we should do is we should ask. Okay, where are the weaknesses here? Where are the places that we have less certainty and can we design an experiment to break the model? So the first thing to recognize I sort of joking I'm not joking, but I say it in a little bit of a harsh way But the first thing I tell everybody in my lab when they come to the lab or and they're trying to think about a project And what's going on? I'm like your models wrong deal with it Your model is an imperfect representation of reality now go figure out where it's wrong And I think that's exactly the way we should be doing Science if we really want to make the most progress because the only way you're gonna get closer To reality is if you figure out where the model doesn't fit So that is the way I train everybody in my lab to approach their research and to be skeptical of what they believe And I think that is I was gonna say the right way But I don't want to I don't want to make it have a moral connotation to it I think it's the approach to science that is most likely to get us to where we want to be which is to understand Whatever it is that we're studying the problem that I see is the reward structure in Certainly biomedical research is set up to do the opposite of that which is to decide what? The answer is and go do experiments to prove the answer and I have seen over and over and over in my career People who ignore data that doesn't fit their model because well the models, right? And it's much easier to publish your paper in high-impact journals if you only show the data that fits your model I mean, it's just a fact and so I have real concerns that that's partly why the field gets led astray with things like resveratrol Because people ignored the data that didn't fit the model and they only published or what sometimes happen is people will do the experiment ten times Nine times it won't work. They'll publish the one time that it does that's a version of Ignoring the data that doesn't fit the model that is rampant in science I mean, I hate to say it but it is everywhere and in fact as I've alluded to the reward structure encourages that and people who do that Tend to be successful in terms of scientific publications and getting grants and then they train their postdocs and graduate students to approach Science that way so I think that's one of the big problems in science right now. I don't have a great Solution. I wish I did and I also want to say I said I don't want to make this about a moral sort of thing Like it's right or wrong. I honestly don't think that Many maybe most of the people who do that recognize what they're doing I think that's the way they've been trained but I think it's a problem and I think it does tend to lead us down wrong roads and Leads to a lot of waste and maybe that's part of the irreproducibility Problems that keep cropping up right that everybody knows about so that's one thought that I have around that approach And I do have to say I've also thought of this I can't say that I'm necessarily doing the people in my lab a favor by training them to do that kind of science because it Makes it harder makes it harder to be successful Who are some scientists and this is always a tricky question because people inevitably Interviewees will say oh, I just thought of another three or four or five or ten people I should have mentioned, but if you were to just off-the-cuff name a few researchers Scientists whatever category you might want to put them in who you find interesting to follow or who other folks might find interesting to follow Who comes to mind I think one of the things that will?
The scientists Matt is following. (02:15:47)
Impact this is exactly what we were just talking about people who do what I consider very high quality work And so I would say one of my longtime collaborators who's also one of my best friends his name is Brian Kennedy He leads the aging Research Institute at National University Singapore very broad View of aging I think somewhat you know similar to me I would say have a pretty broad view of the field and does you know great work in? Everything from purely basic all the way through to now doing stuff in clinical world and Brunette Stanford is another person who is absolutely Fantastic does very sort of cutting-edge research on All sorts of stuff, but particularly in the area of stem cell biology and regeneration. How do you spell her last name BRU in ET? You should sue at Columbia who I mentioned earlier is doing this rapamycin Study of ovarian function and she's sort of unique so she did a lot of work with near bars of life on genetic associations with longevity But but she was one of the few people who actually tried to take a functional approach to that and go beyond just figuring out Okay, this gene seems to be correlated with say Centenarians to look at the specific variant and try to figure out functionally What is that variant doing and she you know she's really a master at? Adopting the very most cutting-edge technologies and applying them Fantastic thank you. I will look into all of those and we'll put those in the show notes at Tim top log slash podcast as well Matt there are million other things we could talk about but we've been going now for almost two and a half hours I think it's probably a good place to begin to wind down and if people would like to hear more of these types of conversations about I'm still struggling to use the right term. What would you say to come up with a word? It's hard to know I mean, I like jarrow science, but it's a little too techie maybe but I think it does capture Like I said that interface between aging biology and what we've been trained to care about which is disease So I like that term and I think it fits so I'm gonna go with jarrow science So if you'd like to hear more conversations like this perhaps around to with Matt at some point related to Geroscience and so on because there is so much noise. There's so much noise so much bullshit. I Want to get some backup batteries for this recording device and pulled up this magazine That was staring in the face on the news thing You're like I can't go 20 steps without something like this staring me in the face And it was just some nonsense that had been thrown together to sell magazines If you'd like to hear more, please let me know on Twitter Matt is there anything else you would like to say point people to in terms of Projects or anything else requests of the audience you'd like to make anything at all? Yeah, two things. So one if you have a dog and you're not part of the dog aging project Please go to the website dog aging project org and nominate your dog to participate We are absolutely still looking to enroll dogs both in the pack and in the clinical trial The thing I want to say is, you know, I don't want to end on the sort of there's so much noise and so much hype it is true. There's also a ton of reason to be super excited about the biology in this field and there is so much Fantastic work happening in the field and exciting and you know some of the interventions that we talked about New stuff that people are discovering around Stem cell function and circulating factors and senescent cells that I think are targetable Not only the new science but also potential therapeutics and then you know some potential moonshots So we didn't talk about epigenetic reprogramming and that is a whole topic on its own there is a lot of noise and misinformation and Exaggeration around epigenetic reprogramming, but it's also an area that I think has a lot of promise So I want to leave your listeners with the knowledge that there is a lot to be optimistic about and I know It's hard sometimes to separate the noise from the signal There's a lot of signal here too, and I would love to come back and do a deep dive on the signal at some point Absolutely Oh cliffhanger. Oh the car literally half off Epigenetic reprogramming will have to wait for around two folks. So let us know if you care say something on Twitter Never said that before my life. All right people can find you. Dr. Matt kaberlein on Kaberlein lab org on Twitter M K Berline. I'm going to spell that MK a E B E R L E I N We will link to everything in the show notes so that people can find it all in one place at Timed up log slash podcast Thank you Matt for taking the time. Thank you. Really enjoyed it really enjoyed it I appreciate you putting up with all of my my plotting around Grasping for things in the dark trying to figure out terminology I really took a ton of notes as you can see right in front of me and everybody out there Until next time be a little kinder than necessary and as always thank you for tuning in Hey guys, this is Tim again just one more thing before you take off and that is five bullet Friday Would you enjoy getting a short email from me every Friday that provides a little fun before the weekend?
Parting thoughts. (02:20:59)
Between one and a half and two million people subscribe to my free newsletter my super short newsletter Called five bullet Friday easy to sign up easy to cancel It is basically a half page that I send out every Friday to share the coolest things I found or discovered or have started exploring over that week kind of like my diary of cool things it often includes articles I'm reading books.
A note from Tim. (02:21:22)
I'm reading albums perhaps Gadgets gizmos all sorts of tech tricks and so on that get sent to me by my friends including a lot of podcast Guests and these strange esoteric things end up in my field and then I test them and then I share them with you So if that sounds fun again It's very short a little tiny bite of goodness before you head off for the weekend something to think about If you'd like to try it out, just go to Tim blog slash Friday type that into your browser Tim dot blog slash Friday drop in your email and you'll get the very next one. Thanks for listening This episode is brought to you by element spelled LM NT what on earth is element?
Sponsor: LMNT. (02:22:32)
It is a delicious sugar-free electrolyte drink mix I've stocked up on boxes and boxes of this was one of the first things that I bought When I saw kopit coming down the pike and I usually use one to two per day Element is formulated to help anyone with their electrolyte needs and perfectly suited to folks following a keto low-carb or paleo diet Or if you drink a ton of water and you might not have the right balance that's often when I drink it or if you're Doing any type of endurance exercise mountain biking etc. Another application if you've ever struggled to feel good on keto low-carb or paleo it's most likely because even if you're consciously consuming electrolytes, you're just not getting enough and Relates to a bunch of stuff like a hormone called aldosterone blah blah blah when insulin is low But suffice to say this is where element again spelled LMNT can help my favorite flavor by far is citrus salt Which is a side note you can also use to make a kick-ass no sugar margarita, but for special occasions, obviously You're probably already familiar with one of the names behind it Rob wolf ro BB Rob wolf who is a former research biochemist and two-time New York Times best-selling author of the paleo solution And wired to eat Rob created element by scratching his own itch That's how it got started his Brazilian jiu-jitsu coaches turned him on to electrolytes as a performance enhancer things clicked and BAM Company was born So if you're on a low-carb diet or fasting electrolytes play a key role in relieving hunger cramps headaches tiredness and dizziness Sugar artificial ingredients coloring all that's garbage unneeded There's none of that in element and a lot of names you might recognize are already using element There's recommend to be by one of my favorite athlete friends three Navy SEAL teams as prescribed by their master chief Marine units FBI sniper teams at least five NFL teams who have subscriptions They are the exclusive hydration partner to team USA weightlifting and on and on you can try it risk-free If you don't like it element will give you your money back. No questions asked They have extremely low return rates for a limited time. You can get a free element sample pack with any purchase It's the perfect way to try all of their flavors or if you're feeling generous sharing with a friend who might enjoy This special offer is available here at this link drink Lmnt.com slash Tim that's drink element drink lmnt.com slash Tim This episode is brought to you by levels very excited about this one I wrote about the health benefits of using continuous glucose monitors CGMS more than 10 years ago in the four-hour body and at that time at CGMS were horribly primitive and hard to use Super painful levels has now made this technology and the insights that come from it easy and available to everyone Putting in the sensors everything about it is smooth easy I found it completely painless and I started tracking my glucose way back in the day to learn more about what I should and shouldn't be eating Keeping my blood sugar stable is critical to my daily and long-term health and performance goals with levels You can see how different foods affect your health with real-time feedback poor glucose control Which you don't want is associated with a number of chronic conditions not just diabetes But also Alzheimer's and heart disease can impact your mood certainly affects my mood energy levels Right that work in the afternoon that dip that you feel for instance That's just one example and weight management and we all respond differently sometimes a little bit sometimes Vastly differently even to the same foods.
Sponsor: Levels. (02:25:00)
So one type of carbohydrate that my body might process Well, let's say that's fruit or rice or sweet potato Your body might not the levels app interprets your glucose data and provides a simple score after you eat a meal So you can see how different foods affect you and then develop a personalized diet That's right for you and your goals Seeing this data in real time at least for me and for so many others who use levels is a really powerful behavioral change mechanism and Many of the guests on the podcast have talked about this Marco Canora famous chef used levels to determine that say walking For him just a few hundred steps after a meal significantly affected his glucose levels Levels is backed by a world-class team and group of advisors including names. You've likely heard before including repeat podcast guest Dr. Dom d'agostino and many others if you're interested in learning more about levels and trying a CGM yourself Learn all about it. Go to levels dot link slash Tim. That's levels dot link slash Tim I'll spell it out Leve LS dot Li n K slash Tim check them out today I highly encourage you to consider getting this data on your own Personal responses to the food that you eat the food that maybe you shouldn't eat the food that you might want to eat more of all of these things you can learn and That is at levels dot link slash Tim. You can also find the link in this episode's description You You You